Edgar Filing: TENET HEALTHCARE CORP

FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

Form 10-Q

x	Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2011

¨	Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to

Commission File Number 1-7293

TENET HEALTHCARE CORPORATION

(Exact name of Registrant as specified in its charter)

Nevada

(State of Incorporation)

95-2557091

(IRS Employer Identification No.)

1445 Ross Avenue, Suite 1400

Dallas, TX 75202

(Address of principal executive offices, including zip code)

(469) 893-2200

(Registrant’s telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company (as defined in Exchange Act Rule 12b-2).


Large accelerated filer x		Accelerated filer ¨		Non-accelerated filer ¨		Smaller reporting company ¨

Indicate by check mark whether the Registrant is a shell company (as defined in Exchange Act Rule 12b-2). Yes ¨ No x

As of October 25, 2011, there were 434,349,003 shares of the Registrant’s common stock, $0.05 par value, outstanding.

TENET HEALTHCARE CORPORATION

TABLE OF CONTENTS


		Page

PART I.	FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)

	Condensed Consolidated Financial Statements		1

	Notes to Condensed Consolidated Financial Statements		4

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		21

Item 3.	Quantitative and Qualitative Disclosures About Market Risk		53

Item 4.	Controls and Procedures		53

PART II.	OTHER INFORMATION

Item 1.	Legal Proceedings		55

Item 1A.	Risk Factors		55

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		55

Item 6.	Exhibits		55

PART I. FINANCIAL INFORMATION

ITEM 1.

FINANCIAL STATEMENTS

TENET HEALTHCARE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

Dollars in Millions

(Unaudited)


	September 30, 2011			December 31, 2010
ASSETS
Current assets:
Cash and cash equivalents	$	185		$	405
Accounts receivable, less allowance for doubtful accounts ($377 at September 30, 2011 and $352 at December 31, 2010)		1,221			1,143
Inventories of supplies, at cost		157			156
Income tax receivable		7			22
Current portion of deferred income taxes		247			282
Assets held for sale		2			14
Other current assets		357			289

Total current assets		2,176			2,311
Investments and other assets		159			164
Deferred income taxes, net of current portion		533			627
Property and equipment, at cost, less accumulated depreciation and amortization ($3,304 at September 30, 2011 and $3,100 at December 31, 2010)		4,201			4,304
Goodwill		724			652
Other intangible assets, at cost, less accumulated amortization ($351 at September 30, 2011 and $302 at December 31, 2010)		500			442

Total assets	$	8,293		$	8,500


LIABILITIES AND EQUITY
Current liabilities:
Current portion of long-term debt	$	129		$	67
Accounts payable		629			720
Accrued compensation and benefits		349			363
Professional and general liability reserves		79			84
Accrued interest payable		111			115
Accrued legal settlement costs		10			8
Other current liabilities		372			368

Total current liabilities		1,679			1,725
Long-term debt, net of current portion		3,966			3,997
Professional and general liability reserves		347			383
Accrued legal settlement costs		22			22
Other long-term liabilities		502			554

Total liabilities		6,516			6,681
Commitments and contingencies
Redeemable noncontrolling interests in equity of consolidated subsidiaries		16			0
Equity:
Shareholders’ equity:
Preferred stock, $0.15 par value; authorized 2,500,000 shares; 345,000 of 7% mandatory convertible shares with a liquidation preference of $1,000 per share issued at September 30, 2011 and December 31, 2010		334			334
Common stock, $0.05 par value; authorized 1,050,000,000 shares; 551,251,384 shares issued at September 30, 2011 and 550,882,110 shares issued at December 31, 2010		27			27
Additional paid-in capital		4,425			4,449
Accumulated other comprehensive loss		(43	)		(43	)
Accumulated deficit		(1,370	)		(1,522	)
Common stock in treasury, at cost, 96,253,367 shares at September 30, 2011 and 65,098,918 shares at December 31, 2010		(1,675	)		(1,479	)

Total shareholders’ equity		1,698			1,766
Noncontrolling interests		63			53

Total equity		1,761			1,819

Total liabilities and equity	$	8,293		$	8,500

See accompanying Notes to Condensed Consolidated Financial Statements.

TENET HEALTHCARE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Dollars in Millions, Except Per-Share Amounts

(Unaudited)


	Three Months Ended September 30,						Nine Months Ended September 30,
	2011			2010			2011			2010
Net operating revenues	$	2,342		$	2,262		$	7,222		$	6,904
Operating expenses:
Salaries, wages and benefits		1,019			977			3,053			2,933
Supplies		388			390			1,191			1,183
Provision for doubtful accounts		193			187			546			549
Other operating expenses, net		547			505			1,581			1,470
Depreciation and amortization		103			101			308			293
Impairment of long-lived assets and goodwill, and restructuring charges, net		8			3			18			1
Litigation and investigation costs		5			2			24			6

Operating income		79			97			501			469
Interest expense		(59	)		(107	)		(275	)		(323	)
Loss from early extinguishment of debt		—			(55	)		—			(55	)
Investment earnings		1			3			3			5

Income (loss) from continuing operations, before income taxes		21			(62	)		229			96
Income tax benefit (expense)		(4	)		1,002			(73	)		979

Income from continuing operations, before discontinued operations		17			940			156			1,075
Discontinued operations:
Loss from operations		(2	)		(4	)		(20	)		(4	)
Impairment of long-lived assets and goodwill, and restructuring charges, net		0			1			0			(1	)
Income tax benefit		0			3			24			0

Income (loss) from discontinued operations		(2	)		0			4			(5	)

Net income		15			940			160			1,070
Less: Preferred stock dividends		6			6			18			18
Less: Net income attributable to noncontrolling interests		3			2			8			7

Net income attributable to Tenet Healthcare Corporation common shareholders	$	6		$	932		$	134		$	1,045

Amounts attributable to Tenet Healthcare Corporation common shareholders
Income from continuing operations, net of tax	$	8		$	932		$	130		$	1,050
Income (loss) from discontinued operations, net of tax		(2	)		0			4			(5	)

Net income attributable to Tenet Healthcare Corporation common shareholders	$	6		$	932		$	134		$	1,045

Earnings (loss) per share attributable to Tenet Healthcare Corporation common shareholders
Basic
Continuing operations	$	0.02		$	1.92		$	0.27		$	2.17
Discontinued operations		0.00			0.00			0.01			(0.01	)

	$	0.02		$	1.92		$	0.28		$	2.16

Diluted
Continuing operations	$	0.02		$	1.68		$	0.26		$	1.91
Discontinued operations		0.00			0.00			0.01			(0.01	)

	$	0.02		$	1.68		$	0.27		$	1.90

Weighted average shares and dilutive securities outstanding (in thousands):
Basic		468,753			485,210			480,817			483,912
Diluted		483,632			559,850			497,862			560,200

See accompanying Notes to Condensed Consolidated Financial Statements.

TENET HEALTHCARE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Dollars in Millions

(Unaudited)


	Nine Months Ended September 30,
	2011			2010
Net income	$	160		$	1,070
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		308			293
Provision for doubtful accounts		546			549
Deferred income tax expense (benefit)		102			(984	)
Stock-based compensation expense		17			18
Impairment of long-lived assets and goodwill, and restructuring charges, net		18			1
Fair market value adjustments related to interest rate swap and LIBOR cap agreements		0			3
Amortization of debt discount and debt issuance costs		23			23
Litigation and investigation costs		24			6
Loss from early extinguishment of debt		0			55
Pre-tax loss from discontinued operations		20			5
Other items, net		(12	)		0
Changes in cash from operating assets and liabilities:
Accounts receivable		(625	)		(537	)
Inventories and other current assets		(36	)		2
Income taxes		(44	)		40
Accounts payable, accrued expenses and other current liabilities		(98	)		(146	)
Other long-term liabilities		(11	)		(23	)
Payments against reserves for restructuring charges and litigation costs		(27	)		(76	)
Net cash used in operating activities from discontinued operations, excluding income taxes		(41	)		(2	)

Net cash provided by operating activities		324			297
Cash flows from investing activities:
Purchases of property and equipment — continuing operations		(298	)		(254	)
Construction of new and replacement hospitals		0			(13	)
Purchase of property and equipment — discontinued operations		0			(13	)
Purchases of businesses or joint venture interests		(56	)		(44	)
Proceeds from sales of facilities and other assets — discontinued operations		0			19
Proceeds from sales of marketable securities, long-term investments and other assets		31			31
Other items, net		(1	)		3

Net cash used in investing activities		(324	)		(271	)
Cash flows from financing activities:
Repayments of borrowings		(4	)		(886	)
Proceeds from borrowings		0			601
Deferred debt issuance costs		0			(15	)
Repurchases of common stock		(196	)		0
Cash dividends on preferred stock		(18	)		(18	)
Distributions paid to noncontrolling interests		(8	)		(6	)
Other items, net		6			6

Net cash used in financing activities		(220	)		(318	)

Net decrease in cash and cash equivalents		(220	)		(292	)
Cash and cash equivalents at beginning of period		405			690

Cash and cash equivalents at end of period	$	185		$	398

Supplemental disclosures:
Interest paid, net of capitalized interest	$	(255	)	$	(313	)
Income tax refunds, net	$	9		$	34

See accompanying Notes to Condensed Consolidated Financial Statements.

TENET HEALTHCARE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1. BASIS OF PRESENTATION

Description of Business

Tenet Healthcare Corporation (together with our subsidiaries, referred to as “Tenet,” the “Company,” “we” or “us”) is an investor-owned health care services company whose subsidiaries and affiliates principally operate acute care hospitals and related health care facilities. At September 30, 2011, our subsidiaries operated 49 acute care hospitals, including four academic medical centers, and one critical access hospital, with a combined total of 13,453 licensed beds, primarily serving urban and suburban communities in 11 states. We also own an interest in a health maintenance organization (“HMO”) and operate: various related health care facilities, including a long-term acute care hospital and a number of medical office buildings (all of which are located on, or nearby, one of our general hospital campuses); revenue cycle management and patient communications services businesses; physician practices; captive insurance companies; a management services subsidiary that provides network development, utilization management, claims processing and contract negotiation services to physician organizations and hospitals that assume managed care risk; and other ancillary health care businesses (including ambulatory surgery centers, diagnostic imaging centers, and occupational and rural health care clinics).

Basis of Presentation

This quarterly report supplements our Annual Report on Form 10-K for the year ended December 31, 2010 (“Annual Report”). As permitted by the Securities and Exchange Commission (“SEC”) for interim reporting, we have omitted certain notes and disclosures that substantially duplicate those in our Annual Report. For further information, refer to the audited Consolidated Financial Statements and notes included in our Annual Report. Unless otherwise indicated, all financial and statistical data included in these notes to our Condensed Consolidated Financial Statements relate to our continuing operations, with dollar amounts expressed in millions (except per-share amounts). Certain prior-year amounts have been reclassified to conform to the current-year presentation.

Although the Condensed Consolidated Financial Statements and related notes within this document are unaudited, we believe all adjustments considered necessary for a fair presentation have been included. In preparing our financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”), we must use estimates and assumptions that affect the amounts reported in our Condensed Consolidated Financial Statements and accompanying notes. We regularly evaluate the accounting policies and estimates we use. In general, we base the estimates on historical experience and on assumptions that we believe to be reasonable given the particular circumstances in which we operate. Actual results may vary from those estimates. Financial and statistical information we report to other regulatory agencies may be prepared on a basis other than GAAP or using different assumptions or reporting periods and, therefore, may vary from amounts presented herein. Although we make every effort to ensure that the information we report to those agencies is accurate, complete and consistent with applicable reporting guidelines, we cannot be responsible for the accuracy of the information they make available to the public.

Operating results for the three and nine month periods ended September 30, 2011 are not necessarily indicative of the results that may be expected for the full year. Reasons for this include, but are not limited to: overall revenue and cost trends, particularly trends in patient accounts receivable collectability and associated provisions for doubtful accounts; the timing and magnitude of price changes; fluctuations in contractual allowances and cost report settlements and valuation allowances; managed care contract negotiations, settlements or terminations and payer consolidations; changes in Medicare and Medicaid regulations; Medicaid funding levels set by the states in which we operate; fluctuations in interest rates; levels of malpractice insurance expense and settlement trends; impairment of long-lived assets and goodwill; restructuring charges; losses, costs and insurance recoveries related to natural disasters; litigation and investigation costs; acquisitions and dispositions of facilities and other assets; income tax rates and deferred tax asset valuation allowance activity; changes in estimates of accruals for annual incentive compensation; the timing and amounts of stock option and restricted stock unit grants to employees and directors; and changes in occupancy levels and patient volumes. Factors that affect patient volumes and, thereby, our results of operations at our hospitals and related health care facilities include, but are not limited to: the business environment, economic conditions and demographics of local communities; the number of uninsured and underinsured individuals in local communities treated at our hospitals; seasonal cycles of illness; climate and weather conditions; physician recruitment, retention and attrition; advances in technology and treatments that reduce length of stay; local health care competitors; managed care contract negotiations or terminations; any unfavorable publicity about us, which impacts our relationships with physicians and patients; changes in health care regulation; and the timing of elective procedures. These considerations apply to year-to-year comparisons as well.

Net Operating Revenues

We recognize net operating revenues in the period in which services are performed. Net operating revenues primarily consist of net patient service revenues that are recorded based on established billing rates (i.e., gross charges), less estimated discounts for contractual and other allowances, principally for patients covered by Medicare, Medicaid, managed care and other health plans, as well as certain uninsured patients under our Compact with Uninsured Patients.

Under certain provisions of the American Recovery and Reinvestment Act of 2009, federal incentive payments are available to hospitals, physicians and certain other professionals (“Providers”) when they adopt certified electronic health record (“EHR”) technology or become “meaningful users” of EHR technology in ways that demonstrate improved quality, safety and effectiveness of care. Providers can become eligible for annual Medicare incentive payments by demonstrating meaningful use of EHR technology in each period over four periods. Medicaid Providers can receive their initial incentive payment by adopting, implementing or upgrading (“AIU”) certified EHR technology, but must demonstrate meaningful use of EHR technology in subsequent years in order to qualify for additional payments. Hospitals may be eligible for both Medicare and Medicaid EHR incentive payments; however, physicians and other professionals may be eligible for either Medicare or Medicaid incentive payments, but not both. Medicaid EHR incentive payments to Providers are 100% federally funded and administered by the states; however, the states are not required to offer EHR incentive payments to Providers. The Centers for Medicare and Medicaid Services (“CMS”) established calendar year 2011 as the first year states could offer EHR incentive payments. Before a state may offer EHR incentive payments, the state must submit and CMS must approve the state’s incentive plan. During the nine months ended September 30, 2011, we acquired certified EHR technology for all of our acute care hospitals and certain of our employed physicians, and CMS approved state plans in all but one state (Nebraska) in which we operate. Accordingly, we are entitled to receive Medicaid incentive payments for the adoption of certified EHR technology for our eligible hospitals and employed physicians in the states that received CMS approval as we have satisfied the statutory and regulatory AIU requirements. As a result, during the nine months ended September 30, 2011, we recognized as revenue approximately $50 million of Medicaid hospital and physician incentive payments, most of which we expect to receive by the end of 2011. Also, if we satisfy specified meaningful use criteria in future periods, we may become entitled to additional Medicaid incentive payments, as well as Medicare incentive payments as further described in the Regulatory and Legislative Changes section in Part II of our Annual Report.

Cash and Cash Equivalents

We treat highly liquid investments with original maturities of three months or less as cash equivalents. Cash and cash equivalents were approximately $185 million and $405 million at September 30, 2011 and December 31, 2010, respectively. As of September 30, 2011 and December 31, 2010, our book overdrafts were approximately $188 million and $243 million, respectively, which were classified as accounts payable.

At September 30, 2011 and December 31, 2010, approximately $81 million and $109 million, respectively, of total cash and cash equivalents in the accompanying Condensed Consolidated Balance Sheets were intended for the operations of our captive insurance subsidiaries. During the nine months ended September 30, 2011, we repatriated $21 million of excess cash from our foreign insurance subsidiary to our corporate domestic bank account.

Also at September 30, 2011 and December 31, 2010, we had $56 million and $91 million, respectively, of property and equipment purchases accrued for items received but not yet paid. Of these amounts, $51 million and $87 million, respectively, were included in accounts payable.

During the nine months ended September 30, 2011, we entered into non-cancellable capital leases of approximately $15 million, primarily for equipment.

NOTE 2. ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS

The principal components of accounts receivable are shown in the table below:


	September 30, 2011			December 31, 2010
Continuing operations:
Patient accounts receivable	$	1,600		$	1,472
Allowance for doubtful accounts		(370	)		(337	)
Estimated future recoveries from accounts assigned to our collection agency subsidiary		56			33
Net cost reports and settlements payable and valuation allowances		(62	)		(26	)

		1,224			1,142
Discontinued operations:
Patient accounts receivable		6			17
Allowance for doubtful accounts		(7	)		(15	)
Estimated future recoveries from accounts assigned to our collection agency subsidiary		0			1
Net cost reports and settlements payable and valuation allowances		(2	)		(2	)

		(3	)		1

Accounts receivable, net	$	1,221		$	1,143

As of September 30, 2011, our estimated collection rates on managed care accounts and self-pay accounts, including co-pays and deductibles, were approximately 98.4% and 27.7%, respectively, which included collections from point-of-service through collections by our collection agency subsidiary. The comparable managed care and self-pay collection rates as of December 31, 2010 were approximately 98.4% and 28.3%, respectively.

Accounts that are pursued for collection through our regional business offices are maintained on our hospitals’ books and reflected in patient accounts receivable with an allowance for doubtful accounts established to reduce the carrying value of such receivables to their estimated net realizable value. We estimate this allowance based on the aging of our accounts receivable by hospital, our historical collection experience by hospital and for each type of payer over an 18-month look-back period, and other relevant factors.

Accounts assigned to our collection agency subsidiary are written off and excluded from patient accounts receivable and allowance for doubtful accounts; however, an estimate of future recoveries from all accounts at our collection agency subsidiary is determined based on historical experience and recorded on our hospitals’ books as a component of accounts receivable in the accompanying Condensed Consolidated Balance Sheets.

The estimated costs (based on selected operating expenses, which include salaries, wages and benefits, supplies and other operating expenses) of caring for our self-pay patients for the three months ended September 30, 2011 and 2010 were approximately $105 million and $97 million, respectively, and for the nine months ended September 30, 2011 and 2010 were approximately $298 million and $285 million, respectively. We also provide charity care to patients who are financially unable to pay for the health care services they receive. Most patients who qualify for charity care are charged a per-diem amount for services received, subject to a cap. Except for the per-diem amounts, our policy is not to pursue collection of amounts determined to qualify as charity care; therefore, we do not report these amounts in net operating revenues or in provision for doubtful accounts. Most states include an estimate of the cost of charity care in the determination of a hospital’s eligibility for Medicaid disproportionate share hospital (“DSH”) payments. Revenues attributable to DSH payments and other state-funded subsidy payments for the three months ended September 30, 2011 and 2010 were approximately $41 million and $37 million, respectively, and for the nine months ended September 30, 2011 and 2010 were approximately $199 million and $134 million, respectively. These payments are intended to mitigate our cost of uncompensated care, as well as reduced Medicaid funding levels. Our estimated costs (based on the selected operating expenses described above) of caring for charity care patients for the three months ended September 30, 2011 and 2010 were $33 million and $36 million, respectively, and for the nine months ended September 30, 2011 and 2010 were $96 million and $90 million, respectively. Our method of measuring the estimated costs uses adjusted self-pay/charity patient days multiplied by selected operating expenses per adjusted patient day. The adjusted self-pay/charity patient days represents actual self-pay/charity patient days adjusted to include self-pay/charity outpatient services by multiplying actual self-pay/charity patient days by the sum of gross self-pay/charity inpatient revenues and gross self-pay/charity outpatient revenues and dividing the results by gross self-pay/charity inpatient revenues.

NOTE 3. DISCONTINUED OPERATIONS

Effective April 1, 2010, we completed the sale of certain of our owned assets at NorthShore Regional Medical Center (“NorthShore”), located in Slidell, Louisiana, for approximately $16 million of cash proceeds. At that time, we also terminated our operating lease agreement for the hospital. We recorded $1 million of net impairment and restructuring charges in discontinued operations during the nine months ended September 30, 2010, consisting of a $3 million write-down of land to expected sales proceeds related to a previously divested hospital, partially offset by $1 million in impairment credits to discontinued operations relating to an increase in the estimated fair values of NorthShore’s long-lived assets, less estimated costs to sell, and $1 million for a reduction in reserves recorded in previous periods.

Net operating revenues and loss before income taxes reported in discontinued operations are as follows:


	Three Months Ended September 30,						Nine Months Ended September 30,
	2011			2010			2011			2010
Net operating revenues	$	(3	)	$	0		$	5		$	22
Loss before income taxes		(2	)		(3	)		(20	)		(5	)

Included in loss before income taxes from discontinued operations in the nine months ended September 30, 2011 is approximately $10 million of expense related to the settlement of two Hurricane Katrina-related class action lawsuits, which amount is net of approximately $10 million of expected recoveries from our reinsurance carriers in connection with the settlement. We had previously recorded a $5 million reserve for this matter as of December 31, 2010.

Should we dispose of additional hospitals or other assets in the future, we may incur additional asset impairment and restructuring charges in future periods.

NOTE 4. IMPAIRMENT AND RESTRUCTURING CHARGES

During the nine months ended September 30, 2011, we recorded $18 million of net impairment and restructuring charges. We recorded $4 million for the write-down of buildings and equipment of one of our previously impaired hospitals to their estimated fair values primarily due to a decline in the fair value of real estate in the market in which the hospital operates and a decline in the estimated fair value of equipment. Material adverse trends in our most recent estimates of future undiscounted cash flows of the hospital, consistent with our previous estimates in prior years when impairment charges were recorded at this hospital, indicated the carrying value of the hospital’s long-lived assets was not recoverable from the estimated future cash flows. We believe the most significant factors contributing to the continuing adverse financial trends include reductions in volumes of insured patients, shifts in payer mix from commercial to governmental payers combined with reductions in reimbursement rates from governmental payers, and high levels of uninsured patients. As a result, we updated the estimate of the fair value of the hospital’s long-lived assets and compared the fair value estimate to the carrying value of the hospital’s long-lived assets. Because the fair value estimate was lower than the carrying value of the hospital’s long-lived assets, an impairment charge was recorded for the difference in the amounts. Unless the anticipated future financial trends of this hospital improve to the extent that the estimated future undiscounted cash flows exceed the carrying value of the long-lived assets, this hospital is at risk of future impairments, particularly if we spend significant amounts of capital at the hospital without generating a corresponding increase in the hospital’s fair value or if the fair value of the hospital’s real estate or equipment continues to decline. We also recorded an impairment charge of $1 million related to a cost basis investment, $7 million in employee severance costs, $3 million in lease termination costs and $3 million of other related costs.

During the nine months ended September 30, 2010, we recorded $1 million of net impairment and restructuring charges. We recorded $3 million for the write-down of buildings, equipment and other long-lived assets, primarily capitalized software costs classified in other intangible assets, of one of our previously impaired hospitals to their estimated fair values primarily due to a decline in the fair value of real estate in the market in which the hospital operates and a decline in the estimated fair value of equipment. This charge was partially offset by a $2 million credit related to the collection of a note receivable due from a buyer of one of our previously divested hospitals, which had been fully reserved in a prior year.

Our impairment tests presume stable, improving or, in some cases, declining results in our hospitals, which are based on programs and initiatives being implemented that are designed to achieve the hospital’s most recent projections. If these projections are not met, or if in the future negative trends occur that impact our future outlook, impairments of long-lived assets and goodwill may occur, and we may incur additional restructuring charges.

As of September 30, 2011, our continuing operations were structured as follows:

•

Our California region included all of our hospitals in California and Nebraska;

•

Our Central region included all of our hospitals in Missouri, Tennessee and Texas;

•

Our Florida region included all of our hospitals in Florida; and

•

Our Southern States region included all of our hospitals in Alabama, Georgia, North Carolina, Pennsylvania and South Carolina.

These regions are reporting units used to perform our goodwill impairment analysis and are one level below our operating segment level. Our hospitals in Pennsylvania, which were previously part of a separate market, became part of our Southern States region effective May 1, 2011. This change did not have any impact on our consolidated financial condition, results of operations or cash flows.

The tables below are reconciliations of beginning and ending liability balances in connection with restructuring charges recorded during the nine months ended September 30, 2011 and 2010 in continuing and discontinued operations:


	Balances at Beginning of Period		Restructuring Charges, Net			Cash Payments			Other			Balances at End of Period
Nine Months Ended September 30, 2011
Continuing operations:
Lease and other costs, and employee severance-related costs in connection with hospital cost-control programs and general overhead-reduction plans	$	4	$	13		$	(6	)	$	(1	)	$	10
Discontinued operations:
Employee severance-related costs, and other estimated costs associated with the sale or closure of hospitals and other facilities		6		0			(1	)		0			5

	$	10	$	13		$	(7	)	$	(1	)	$	15


Nine Months Ended September 30, 2010
Continuing operations:
Lease and other costs, and employee severance-related costs in connection with hospital cost-control programs and general overhead-reduction plans	$	6	$	0		$	(3	)	$	0		$	3
Discontinued operations:
Employee severance-related costs, and other estimated costs associated with the sale or closure of hospitals and other facilities		8		(1	)		(1	)		0			6

	$	14	$	(1	)	$	(4	)	$	0		$	9

The above liability balances at September 30, 2011 are included in other current liabilities and other long-term liabilities in the accompanying Condensed Consolidated Balance Sheet. Cash payments to be applied against these accruals at September 30, 2011 are expected to be approximately $3 million in 2011 and $12 million thereafter.

NOTE 5. LONG-TERM DEBT AND LEASE OBLIGATIONS

The table below shows our long-term debt as of September 30, 2011 and December 31, 2010:


	September 30, 2011			December 31, 2010
Senior notes:
6³/₈%, due 2011	$	65		$	65
6¹/₂%, due 2012		57			57
7³/₈%, due 2013		216			216
9⁷/₈%, due 2014		60			60
9¹/₄%, due 2015		474			474
8%, due 2020		600			600
6⁷/₈%, due 2031		430			430
Senior secured notes:
9%, due 2015		714			714
10%, due 2018		714			714
8⁷/₈%, due 2019		925			925
Capital leases and mortgage notes		21			6
Unamortized note discounts		(181	)		(197	)

Total long-term debt		4,095			4,064
Less: Current portion		129			67

Long-term debt, net of current portion	$	3,966		$	3,997

Credit Agreement

We have a senior secured revolving credit facility that provides, subject to borrowing availability, for revolving loans in an aggregate principal amount of up to $800 million, with a $300 million subfacility for standby letters of credit. The credit agreement is scheduled to expire on October 19, 2015; however, this date could be accelerated to as early as the fourth quarter of 2014 if 80% of our notes due in 2015 are not repaid, defeased or refinanced 60 business days prior to their maturity. The revolving credit facility is collateralized by patient accounts receivable of all of our wholly owned acute care and specialty hospitals. In addition, borrowings under the credit agreement are guaranteed by our wholly owned hospital subsidiaries. Outstanding revolving loans accrue interest during a six-month initial period at the rate of either (i) a base rate plus a margin of 2.00% or (ii) the London Interbank Offered Rate (“LIBOR”) plus a margin of 3.00% per annum. Thereafter, outstanding revolving loans accrue interest at a base rate plus a margin ranging from 1.75% to 2.25% or LIBOR plus a margin ranging from 2.75% to 3.25% per annum based on available credit. An unused commitment fee will be payable on the undrawn portion of the revolving loans at a six-month initial rate of 0.50% per annum. Thereafter, the unused commitment fee will range from 0.375% to 0.625% per annum based on available credit. Our borrowing availability is based on a specified percentage of eligible accounts receivable, including self-pay accounts. There were no cash borrowings outstanding under the revolving credit facility at September 30, 2011, and we had approximately $169 million of standby letters of credit outstanding. Based on our eligible receivables, approximately $540 million was available for borrowing under the revolving credit facility at September 30, 2011.

Interest Rate Swap and LIBOR Cap Agreements

We were party to an interest rate swap agreement for an aggregate notional amount of $600 million from February 14, 2011 through August 2, 2011. The interest rate swap agreement was designated as a fair value hedge and was being used to manage our exposure to future changes in interest rates. It had the effect of converting our 10% senior secured notes due 2018 from a fixed interest rate paid semi-annually to a variable interest rate paid semi-annually based on the six-month LIBOR plus a floating rate spread of 6.60%. During the term of the interest rate swap agreement, changes in the fair value of the interest rate swap agreement and changes in the fair value of the 10% senior secured notes, which we expected to substantially offset each other, were recorded in interest expense. During the nine months ended September 30, 2011, our interest rate swap agreement generated approximately $8 million of cash interest savings and a $22 million gain on the settlement of the agreement.

The fair value of the LIBOR cap agreement included in investments and other assets in the accompanying Condensed Consolidated Balance Sheet at September 30, 2011 totaled less than $1 million. During the nine months ended September 30, 2011, mark-to-market adjustments of the LIBOR cap agreement did not have a material impact on interest expense in the accompanying Condensed Consolidated Statements of Operations. In addition, see Note 14 for the disclosure of the fair value of the LIBOR cap agreement.

NOTE 6. GUARANTEES

Consistent with our policy on physician relocation and recruitment, we provide income guarantee agreements to certain physicians who agree to relocate to fill a community need in the service area of one of our hospitals and commit to remain in practice in the area for a specified period of time. Under such agreements, we are required to make payments to the physicians in excess of the amounts they earn in their practices up to the amount of the income guarantee. The income guarantee periods are typically 12 months. If a physician does not fulfill his or her commitment period to the community, which is typically three years subsequent to the guarantee period, we seek recovery of the income guarantee payments from the physician on a prorated basis. We also provide revenue collection guarantees to hospital-based physician groups providing certain services at our hospitals with terms generally ranging from one to three years.

At September 30, 2011, the maximum potential amount of future payments under our income and revenue collection guarantees was $87 million. We had a liability of $76 million recorded for the fair value of these guarantees included in other current liabilities at September 30, 2011.

We have also guaranteed minimum rent revenue to certain landlords who built medical office buildings on or near our hospital campuses. The maximum potential amount of future payments under these guarantees at September 30, 2011 was $7 million. We had a liability of $5 million recorded for the fair value of these guarantees, of which $1 million was included in other current liabilities and $4 million was included in other long-term liabilities, at September 30, 2011.

NOTE 7. EMPLOYEE BENEFIT PLANS

At September 30, 2011, approximately 22 million shares of common stock were available under our 2008 Stock Incentive Plan for future stock option grants and other incentive awards, including restricted stock units. Options have an exercise price equal to the fair market value of the shares on the date of grant and generally expire 10 years from the date of grant. A restricted stock unit is a contractual right to receive one share of our common stock or, in some cases, the equivalent value in cash in the future. Options and restricted stock units typically vest one-third on each of the first three anniversary dates of the grant; however, from time to time, we grant performance-based options and restricted stock units that vest subject to the achievement of specified performance goals within a specified timeframe.

Our income from continuing operations for the nine months ended September 30, 2011 and 2010 includes $17 million and $18 million, respectively, of pre-tax compensation costs related to our stock-based compensation arrangements.

Stock Options

The following table summarizes stock option activity during the nine months ended September 30, 2011:


	Options			Weighted Average Exercise Price Per Share		Aggregate Intrinsic Value		Weighted Average Remaining Life
						(In Millions)
Outstanding as of December 31, 2010		43,155,549		$	9.97
Granted		0			0
Exercised		(2,465,783	)		1.31
Forfeited/Expired		(4,016,924	)		28.02

Outstanding as of September 30, 2011		36,672,842		$	8.57	$	48		5.2 years

Vested and expected to vest at September 30, 2011		36,541,652		$	8.60	$	48		5.2 years

Exercisable as of September 30, 2011		29,415,190		$	10.32	$	29		4.6 years

There were 2,465,783 stock options exercised during the nine months ended September 30, 2011 with a $14 million aggregate intrinsic value, and 1,823,678 stock options exercised during the same period in 2010 with a $8 million aggregate intrinsic value.

In the nine months ended September 30, 2011, there were no stock options granted. In the nine months ended September 30, 2010, there were 964,008 stock options granted under our 2008 Stock Incentive Plan.

As of September 30, 2011, there were $3 million of total unrecognized compensation costs related to stock options. These costs are expected to be recognized over a weighted average period of 0.8 years.

The following table summarizes information about our outstanding stock options at September 30, 2011:


	Options Outstanding						Options Exercisable
Range of Exercise Prices	Number of Options		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number of Options		Weighted Average Exercise Price
$0.00 to $1.149		16,042,131		7.4 years	$	1.14		9,540,752	$	1.14
$1.15 to $10.639		10,998,516		5.2 years		7.26		10,242,243		7.45
$10.64 to $13.959		2,879,551		2.4 years		12.11		2,879,551		12.11
$13.96 to $17.589		3,594,422		1.3 years		17.09		3,594,422		17.09
$17.59 to $28.759		612,000		1.1 years		28.16		612,000		28.16
$28.76 and over		2,546,222		0.2 years		40.37		2,546,222		40.37

		36,672,842		5.2 years	$	8.57		29,415,190	$	10.32

Restricted Stock Units

The following table summarizes restricted stock unit activity during the nine months ended September 30, 2011:


	Restricted Stock Units			Weighted Average Grant Date Fair Value Per Unit
Unvested as of December 31, 2010		6,321,270		$	5.14
Granted		4,274,884			6.89
Vested		(2,557,367	)		5.00
Forfeited		(214,217	)		5.89

Unvested as of September 30, 2011		7,824,570		$	6.12

In the nine months ended September 30, 2011, we granted 3,519,448 restricted stock units subject to time-vesting. In addition, we granted 755,436 performance-based restricted stock units to certain of our senior officers. If all conditions are met, the performance-based restricted stock units will vest and be settled ratably over a three-year period from the date of the grant.

As of September 30, 2011, there were $33 million of total unrecognized compensation costs related to restricted stock units. These costs are expected to be recognized over a weighted average period of 2.3 years.

NOTE 8. EQUITY

We accrued approximately $6 million, or $17.50 per share, for dividends on our 7% mandatory convertible preferred stock in each of the three months ended March 31, 2011, June 30, 2011 and September 30, 2011, and paid the dividends in April 2011, July 2011 and October 2011, respectively.

On September 7, 2011, we entered into an amendment to our Section 382 Rights Agreement dated as of January 7, 2011 (the “Rights Agreement”) to accelerate the final expiration date of the rights issued under the Rights Agreement to the close of business on September 12, 2011. Accordingly, as of the close of business on September 12, 2011, the rights issued under the Rights Agreement expired and are no longer outstanding.

On May 9, 2011, we announced that our board of directors had authorized the repurchase of up to $400 million of our common stock through a share repurchase program. Under the program, shares may be purchased in the open market or through privately negotiated transactions in a manner consistent with applicable securities laws and regulations, including pursuant to a Rule 10b5-1 plan maintained by the Company. Shares will be repurchased at times and in amounts based on market conditions and other factors. The share repurchase program does not obligate us to acquire any specific number of shares and may be modified, suspended or discontinued at any time. The share repurchase program will expire on May 9, 2012. Pursuant to the program, we repurchased a total of 35,478,972 shares for approximately $196 million during the nine months ended September 30, 2011 as shown in the following table:


Period	Total Number of Shares Purchased		Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Program		Maximum Dollar Value of Shares That May Yet Be Purchased Under the Program
May 12, 2011 through May 31, 2011		4,582,299	$	6.44		4,582,299	$	370,475,865
June 1, 2011 through June 30, 2011		6,882,130		6.17		6,882,130		328,002,443

Three Months Ended June 30, 2011		11,464,429		6.28		11,464,429		328,002,443

July 1, 2011 through July 31, 2011		5,354,419		6.16		5,354,419		295,011,008
August 1, 2011 through August 31, 2011		11,326,556		5.02		11,326,556		238,182,249
September 1, 2011 through September 30, 2011		7,333,568		4.63		7,333,568		204,221,164

Three Months Ended September 30, 2011		24,014,543		5.15		24,014,543		204,221,164

Total		35,478,972	$	5.52		35,478,972	$	204,221,164

Repurchased shares are recorded based on settlement date and are held as treasury stock.

The following table shows the changes in consolidated equity during the nine months ended September 30, 2011 and 2010 (dollars in millions, share amounts in thousands):


	Tenet Healthcare Corporation Shareholders’ Equity
	Preferred Stock				Common Stock
	Shares Outstanding		Issued Amount		Shares Outstanding			Issued Par Amount		Additional Paid-in Capital			Accumulated Other Comprehensive Loss			Accumulated Deficit			Treasury Stock			Noncontrolling Interests			Total Equity
Balances at December 31, 2010		345,000	$	334		485,783		$	27	$	4,449		$	(43	)	$	(1,522	)	$	(1,479	)	$	53		$	1,819
Net income		0		0		0			0		0			0			152			0			8			160
Distributions paid to noncontrolling interests		0		0		0			0		0			0			0			0			(8	)		(8	)
Purchases of businesses or joint venture interests		0		0		0			0		0			0			0			0			10			10
Preferred stock dividends		0		0		0			0		(18	)		0			0			0			0			(18	)
Repurchases of common stock		0		0		(35,479	)		0		0			0			0			(196	)		0			(196	)
Stock-based compensation expense, including associated deferred tax asset adjustments, and issuance of common stock		0		0		4,694			0		(6	)		0			0			0			0			(6	)

Balances at September 30, 2011		345,000	$	334		454,998		$	27	$	4,425		$	(43	)	$	(1,370	)	$	(1,675	)	$	63		$	1,761


Balances at December 31, 2009		345,000	$	334		481,135		$	27	$	4,461		$	(32	)	$	(2,665	)	$	(1,479	)	$	51		$	697
Net income		0		0		0			0		0			0			1,063			0			7			1,070
Distributions paid to noncontrolling interests		0		0		0			0		0			0			0			0			(6	)		(6	)
Contributions from noncontrolling interests		0		0		0			0		0			0			0			0			1			1
Other comprehensive income		0		0		0			0		0			2			0			0			0			2
Preferred stock dividends		0		0		0			0		(18	)		0			0			0			0			(18	)
Stock-based compensation expense and issuance of common stock		0		0		4,192			0		18			0			0			0			0			18

Balances at September 30, 2010		345,000	$	334		485,327		$	27	$	4,461		$	(30	)	$	(1,602	)	$	(1,479	)	$	53		$	1,764

NOTE 9. OTHER COMPREHENSIVE INCOME

The table below shows each component of other comprehensive income for the three and nine months ended September 30, 2011 and 2010:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2011		2010		2011		2010
Net income	$	15	$	940	$	160	$	1,070
Other comprehensive income
Unrealized gains on securities available for sale		0		0		0		1
Reclassification adjustments for realized losses included in net income		0		1		0		1

Other comprehensive income before income taxes		0		1		0		2
Income tax expense related to items of other comprehensive income		0		0		0		0

Total other comprehensive income, net of tax		0		1		0		2

Comprehensive income		15		941		160		1,072
Less: Preferred stock dividends		6		6		18		18
Less: Comprehensive income attributable to noncontrolling interests		3		2		8		7

Comprehensive income attributable to Tenet Healthcare Corporation common shareholders	$	6	$	933	$	134	$	1,047

NOTE 10. PROPERTY AND PROFESSIONAL AND GENERAL LIABILITY INSURANCE

Property Insurance

We have property, business interruption and related insurance coverage to mitigate the financial impact of catastrophic events or perils that is subject to deductible provisions based on the terms of the policies. These policies are on an occurrence basis. For the policy periods April 1, 2011 through March 31, 2012 and April 1, 2010 through March 31, 2011, we have coverage totaling $600 million per occurrence, after deductibles and exclusions, with annual aggregate sub-limits of $100 million each for floods and earthquakes and a per-occurrence sub-limit of $100 million for windstorms with no annual aggregate. With respect to fires and other perils, excluding floods, earthquakes and windstorms, the total $600 million limit of coverage per occurrence applies. Deductibles are 5% of insured values up to a maximum of $25 million for floods, California earthquakes and wind-related claims, and 2% of insured values for New Madrid fault earthquakes, with a maximum per claim deductible of $25 million. Other covered losses, including fires and other perils, have a minimum deductible of $1 million.

Professional and General Liability Insurance

At September 30, 2011 and December 31, 2010, the aggregate current and long-term professional and general liability reserves in our accompanying Condensed Consolidated Balance Sheets were approximately $426 million and $467 million, respectively. These reserves include the reserves recorded by our captive insurance subsidiaries and our self-insured retention reserves recorded based on actuarial estimates for the portion of our professional and general liability risks, including incurred but not reported claims, for which we do not have insurance coverage. We estimated the reserves for losses and related expenses using expected loss-reporting patterns discounted to their present value under a risk-free rate approach using a Federal Reserve seven-year maturity rate of 1.43% and 2.71% at September 30, 2011 and December 31, 2010, respectively.

For the policy period June 1, 2011 through May 31, 2012, our hospitals generally have a self-insurance retention of $5 million per occurrence for all claims incurred. Our captive insurance company, The Healthcare Insurance Corporation (“THINC”), retains $10 million per occurrence coverage above our hospitals’ $5 million self-insurance retention level. The next $10 million of claims in excess of these aggregate self-insurance retentions of $15 million per occurrence are 65% reinsured by THINC with independent reinsurance companies, with THINC retaining 35% or a maximum of $3.5 million. Claims in excess of $25 million are covered by our excess professional and general liability insurance policies with major independent insurance companies, on a claims-made basis, subject to an aggregate limit of $175 million.

For the policy period June 1, 2010 through May 31, 2011, our hospitals generally have a self-insurance retention of $5 million per occurrence for all claims incurred. THINC retains $10 million per occurrence coverage above our hospitals’ $5 million self-insurance retention level. The next $10 million of claims in excess of these aggregate self-insurance retentions of $15 million per occurrence are 55% reinsured by THINC with independent reinsurance companies, with THINC retaining 45% or a maximum of $4.5 million. Claims in excess of $25 million are covered by our excess professional and general liability insurance policies with major independent insurance companies, on a claims-made basis, subject to an aggregate limit of $175 million.

If the aggregate limit of any of our excess professional and general liability policies is exhausted, in whole or in part, it could deplete or reduce the excess limits available to pay any other material claims applicable to that policy period.

NOTE 11. CLAIMS AND LAWSUITS

Because we provide health care services in a highly regulated industry, we have been and expect to continue to be party to various lawsuits, claims and regulatory proceedings from time to time. The ultimate resolution of these matters, individually or in the aggregate, whether as a result of litigation or settlement, could have a material adverse effect on our business (both in the near and long term), financial condition, results of operations or cash flows. We are currently a party to a number of legal and regulatory proceedings, including those reported below. Where specific amounts are sought in any of the following matters, those amounts are disclosed. For all other matters discussed below, where a loss is reasonably possible and estimable, an estimate of the loss or a range of loss is provided. In cases where we have not provided an estimate, a loss is not reasonably possible or an amount of loss is not reasonably estimable at this time.

1.	Governmental Reviews—Our hospitals are subject to regulatory reviews from time to time; the following matters, which have been previously reported, are currently ongoing.

•

Inpatient Rehabilitation Facilities Review. Pursuant to the five-year corporate integrity agreement (“CIA”) we entered into with the Office of Inspector General (“OIG”) of the U.S. Department of Health and Human Services in September 2006, we notified the OIG in October 2007 that we had completed a preliminary review of admissions to our inpatient rehabilitation unit at South Fulton Medical Center in East Point, Georgia that suggested further review was necessary to determine whether South Fulton had received Medicare overpayments reportable under the CIA. In January 2008, we submitted this matter into the OIG’s voluntary self-disclosure protocol. The OIG subsequently accepted our submission. In February 2009, we received a letter from the U.S. Department of Justice (“DOJ”), which is participating in this matter with the OIG, requesting additional information regarding the basis for our self-disclosure, as well as information related to admissions at our other active and divested inpatient rehabilitation hospitals and units for the period 2000 to the date of the letter. The government has since limited the scope of its review to the period May 15, 2005 through December 31, 2007. In addition, the government asked to examine a limited sample of patient files at two inpatient rehabilitation facilities besides South Fulton before it determined whether its review should extend to other inpatient rehabilitation units we currently own or formerly owned. That examination was completed and presented to the government in March 2010. We met with the DOJ in October 2010 and January 2011 to discuss the examination originally presented to the DOJ in March 2010. Beginning in April 2011, the DOJ initiated a series of informal, non-binding and exploratory discussions with us about a potential non-judicial resolution of this matter. To date, the parties have not been able to agree on a framework under which they would be willing to enter into formal settlement discussions, including the statistical assumptions and other methodologies that might be used to compute a hypothetical range of liability based on the examinations. Because of these differences, it is not currently possible to predict the potential outcome of our discussions with the DOJ and, consequently, we have reserved all rights to contest any claims that the DOJ may assert. We continue to pursue discussions with the DOJ in hopes of agreeing upon a framework under which the parties might be able to settle this matter; however, it is impossible at this time to predict the outcome of those discussions or the amount of any potential resolution.

•

Kyphoplasty Review. The DOJ, through the U.S. Attorney’s Office in the Western District of New York, in conjunction with the OIG, has contacted a number of hospitals, including several of our hospitals, requesting information regarding their billing practices for kyphoplasty procedures. Kyphoplasty is a surgical procedure used to treat pain and related conditions associated with certain vertebrae injuries. The government requested the information in connection with its review of the appropriateness of Medicare patients receiving kyphoplasty procedures on an inpatient as opposed to an outpatient basis. We continue to fully cooperate with the government regarding its review.

•

Review of Florida Medical Center’s Partial Hospitalization Program. In February 2009, the fiscal intermediary for our Florida Medical Center began a probe review of the group billing practices of that facility’s partial hospitalization program, a psychiatric treatment program that had the capacity to treat 15 patients on an outpatient basis. We also examined the records reviewed by the fiscal intermediary and independently determined that patients had multiple outpatient admissions with lengths of stay longer than expected for this type of program. As a result of our review of this matter, we closed the program and, pursuant to the CIA, notified the OIG about our findings in June 2009. In November 2010, we submitted this matter into the OIG’s voluntary self-disclosure protocol. The OIG subsequently accepted our submission. We continue to fully cooperate with the government regarding its review.

•

Review of ICD Implantation Procedures. In March 2010, the DOJ issued a civil investigative demand (“CID”) pursuant to the federal False Claims Act to one of our hospitals. The CID requested information regarding Medicare claims submitted by our hospital in connection with the implantation of implantable cardioverter defibrillators (“ICDs”) during the period 2002 to the date of the letter. The government is seeking this information to determine if ICD implantation procedures were performed in accordance with Medicare coverage requirements. In September 2010, the DOJ notified us that it also intends to review records and documents from a number of our other hospitals in addition to the hospital that originally received the CID. We understand that the DOJ has submitted similar requests to other hospital companies as well. We continue to fully cooperate with the government regarding its review.

Our analysis of several of these matters is still ongoing, and we are unable to predict the timing and outcome of these reviews and any discussions with government agencies at this time. However, based on the status of these matters to date, we have recorded reserves of approximately $27 million as of September 30, 2011. We cannot predict the ultimate resolution of any governmental review, and the final amounts paid in settlement or otherwise, if any, could differ materially from our current recorded reserves.

Pending Wage and Hour Actions—As previously reported, we are defendants in two coordinated lawsuits in Los Angeles Superior Court alleging that our hospitals violated certain provisions of California’s labor laws and applicable wage and hour regulations. The plaintiffs in both cases have sought back pay, statutory penalties, interest and attorneys’ fees. The plaintiffs’ requests for class certification were ultimately denied in November 2008. The plaintiffs subsequently filed a notice of appeal of the court’s decision; however, in February 2011, the court of appeal affirmed the lower court’s November 2008 ruling. The plaintiffs filed a petition for review with the California Supreme Court, which was granted, but the court has deferred further action in the matter pending its ruling in a similar case. We are also subject from time to time to regulatory proceedings and private litigation concerning the application of various federal and state labor laws, rules and regulations governing a variety of workplace wage and hour issues.

Class Action Lawsuits Resulting from Hurricane Katrina—In March 2011, following the commencement of trial proceedings in the Civil District Court for the Parish of Orleans, we agreed to settle two previously reported class action lawsuits brought on behalf of patients, their family members and others who were present and allegedly injured at Memorial Medical Center, one of our former New Orleans area hospitals, during Hurricane Katrina and its aftermath. A $25 million cash settlement payment, which was fully reserved at March 31, 2011, will be apportioned among the approximately 1,400 eligible class members who file a proof of claim in the cases. The court approved the final settlement agreement at a fairness hearing held on October 27, 2011.

Six lawsuits filed by plaintiffs who chose to opt out of the class proceedings involving Memorial Medical Center remain pending at this time. As of September 30, 2011, trial dates had not been set in these individual cases. In addition, a third previously reported purported class action lawsuit (also filed in the Civil District Court for the Parish of Orleans) remains pending. The class certification hearing in that action, which was brought on behalf of patients, their family members and others who were present and allegedly injured following Hurricane Katrina at Lindy Boggs Medical Center, another one of our former New Orleans area hospitals, was postponed in late 2010 and has not yet been rescheduled. Furthermore, 11 individual Hurricane Katrina-related lawsuits remain pending against Lindy Boggs and two other New Orleans-area hospitals that we have since divested – Meadowcrest Hospital and Kenner Regional Medical Center. In general, the plaintiffs allege that the hospitals were negligent in failing to properly prepare for the storm, failing to evacuate patients ahead of the storm, and failing to have properly configured emergency generator systems, among other allegations of general negligence. The plaintiffs seek damages in various and unspecified amounts for the alleged wrongful death of some patients, aggravation of pre-existing illnesses or injuries to patients who survived and were successfully evacuated, and the inability of patients and others to evacuate the hospitals for several days under challenging conditions. We are unable to predict the ultimate resolution of the pending lawsuits, but we intend to continue to vigorously defend the hospitals in these matters.

Shareholder Suits—In May and July 2011, five lawsuits filed in connection with an unsolicited proposal to acquire the Company were dismissed at the request of the separate plaintiffs. A sixth lawsuit was dismissed by the Second Judicial Court in the State of Nevada in March 2011. No shareholder suits remain outstanding at this time.

5.	Lawsuit Against Community Health Systems—On April 11, 2011, we filed a lawsuit in the United States District Court for the Northern District of Texas alleging violations of federal securities laws against Community Health Systems, Inc.

(“Community”), its chairman and chief executive officer, Wayne T. Smith, and its chief financial officer, W. Larry Cash. The lawsuit seeks to compel Community to correct statements made in its proxy solicitations to Tenet shareholders in connection with Community’s unsolicited proposal to acquire the Company by disclosing fully and accurately its practices with respect to inpatient admissions and the liabilities related to those practices. The lawsuit also seeks the award of costs associated with the investigation of the defendants’ materially false and misleading proxy solicitations. Community has filed a motion to dismiss the lawsuit, and we have filed our response to that motion, which remains pending before the court.

Ordinary Course Matters—In addition to the matters described above, our hospitals are subject to investigations, claims and lawsuits in the ordinary course of our business. Most of these matters involve allegations of medical malpractice or other injuries suffered at our hospitals. Our hospitals are also routinely subject to sales and use tax audits and personal property tax audits by the state and local government jurisdictions in which they do business. The results of the audits are frequently disputed, and such disputes are ordinarily resolved by administrative appeals or litigation.

New claims or inquiries may be initiated against us from time to time. These matters could (1) require us to pay substantial damages or amounts in judgments or settlements, which individually or in the aggregate could exceed amounts, if any, that may be recovered under our insurance policies where coverage applies and is available, (2) cause us to incur substantial expenses, (3) require significant time and attention from our management, and (4) cause us to close or sell hospitals or otherwise modify the way we conduct business.

We record reserves for claims, lawsuits and regulatory proceedings when they are probable and can be reasonably estimated. For matters where the likelihood or extent of a loss is not probable or cannot be reasonably estimated, we have not recognized the potential liabilities that may result in the accompanying Condensed Consolidated Financial Statements.

The table below presents reconciliations of the beginning and ending liability balances in connection with legal settlements and related costs recorded during the nine months ended September 30, 2011 and 2010:


	Balances at Beginning of Period		Litigation and Investigation Costs		Cash Payments			Other		Balances at End of Period
Nine Months Ended September 30, 2011
Continuing operations	$	30	$	24	$	(22	)	$	0	$	32
Discontinued operations		0		0		0			0		0

	$	30	$	24	$	(22	)	$	0	$	32

Nine Months Ended September 30, 2010
Continuing operations	$	95	$	6	$	(72	)	$	1	$	30
Discontinued operations		0		0		0			0		0

	$	95	$	6	$	(72	)	$	1	$	30

For the nine months ended September 30, 2011 and 2010, we recorded net costs of $24 million and $6 million, respectively. The 2011 amount is comprised of costs associated with the unsolicited acquisition proposal we received from Community, a settlement with the California Nurses Association, an accrual for a physician privileges case where an unfavorable jury verdict (subject to appeal) was rendered against us, and costs associated with the legal proceedings and governmental reviews described above. The 2010 amount is comprised of costs associated with the legal proceedings and governmental reviews described above.

NOTE 12. INCOME TAXES

Income tax expense in the nine months ended September 30, 2011 included a benefit of $30 million ($12 million related to continuing operations and $18 million related to discontinued operations) attributable to a reduction in our estimated liabilities for uncertain tax positions, net of related deferred tax effects. The total amount of unrecognized tax benefits as of September 30, 2011 was $20 million ($19 million related to continuing operations and $1 million related to discontinued operations), which, if recognized, would impact our effective tax rate and income tax expense (benefit) from continuing and discontinued operations.

Our practice is to recognize interest and penalties related to income tax matters in income tax expense in our consolidated statements of operations. Approximately $0.9 million of interest and penalties related to accrued liabilities for

uncertain tax positions ($0.6 million of income related to continuing operations and $1.5 million of expense related to discontinued operations) are included in the accompanying Condensed Consolidated Statement of Operations for the nine months ended September 30, 2011. Total accrued interest and penalties on unrecognized tax benefits as of September 30, 2011 were $6 million.

As of September 30, 2011, approximately $4 million of unrecognized federal and state tax benefits, as well as reserves for interest and penalties, may decrease in the next 12 months as a result of the settlement of audits, the filing of amended tax returns or the expiration of statutes of limitations.

NOTE 13. EARNINGS PER COMMON SHARE

The table below is a reconciliation of the numerators and denominators of our basic and diluted earnings per common share calculations for income from continuing operations for the three and nine months ended September 30, 2011 and 2010. Income is expressed in millions and weighted average shares are expressed in thousands.


	Income (Numerator)		Weighted Average Shares (Denominator)		Per- Share Amount
Three Months Ended September 30, 2011
Income available to Tenet Healthcare Corporation common shareholders for basic earnings per share	$	8		468,753	$	0.02
Effect of dilutive stock options and restricted stock units		0		14,879		0.00

Income available to Tenet Healthcare Corporation common shareholders for diluted earnings per share	$	8		483,632	$	0.02

Three Months Ended September 30, 2010
Income available to Tenet Healthcare Corporation common shareholders for basic earnings per share	$	932		485,210	$	1.92
Effect of dilutive stock options, restricted stock units and mandatory convertible preferred stock		6		74,640		(0.24	)

Income available to Tenet Healthcare Corporation common shareholders for diluted earnings per share	$	938		559,850	$	1.68

Nine Months Ended September 30, 2011
Income available to Tenet Healthcare Corporation common shareholders for basic earnings per share	$	130		480,817	$	0.27
Effect of dilutive stock options and restricted stock units		0		17,045		(0.01	)

Income available to Tenet Healthcare Corporation common shareholders for diluted earnings per share	$	130		497,862	$	0.26

Nine Months Ended September 30, 2010
Income available to Tenet Healthcare Corporation common shareholders for basic earnings per share	$	1,050		483,912	$	2.17
Effect of dilutive stock options, restricted stock units and mandatory convertible preferred stock		18		76,288		(0.26	)

Income available to Tenet Healthcare Corporation common shareholders for diluted earnings per share	$	1,068		560,200	$	1.91

Stock options (in thousands) whose exercise price exceeded the average market price of our common stock and, therefore, were not included in the computation of diluted shares for the three and nine months ended September 30, 2011 were 16,355 and 16,215 shares, respectively, and for the three and nine months ended September 30, 2010 were 26,260 and 22,243 shares, respectively.

NOTE 14. FAIR VALUE MEASUREMENTS

Our financial assets and liabilities recorded at fair value on a recurring basis primarily relate to investments in available-for-sale securities held by our captive insurance subsidiaries and our derivative contracts. The following tables present information about our assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2011 and December 31, 2010. The following tables also indicate the fair value hierarchy of the valuation techniques we utilized to determine such fair values. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. We consider a security that trades at least weekly to have an active market. Fair values determined by Level 2 inputs utilize data points that are observable, such as quoted prices, interest rates and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability.


Investments:	September 30, 2011		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Marketable securities—current	$	1	$	1	$	0	$	0
Investments in Reserve Yield Plus Fund		2		0		2		0
Marketable debt securities—noncurrent		23		7		15		1

	$	26	$	8	$	17	$	1

Derivative Contracts (see Note 5):
LIBOR cap agreement asset	$	0	$	0	$	0	$	0


Investments:	December 31, 2010		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Investments in Reserve Yield Plus Fund	$	1	$	0	$	1	$	0
Marketable debt securities—noncurrent		26		8		17		1

	$	27	$	8	$	18	$	1

Derivative Contract (see Note 5):
LIBOR cap agreement asset	$	0	$	0	$	0	$	0

Our non-financial assets and liabilities not permitted or required to be measured at fair value on a recurring basis typically relate to long-lived assets held and used, long-lived assets held for sale and goodwill. We are required to provide additional disclosures about fair value measurements as part of our financial statements for each major category of assets and liabilities measured at fair value on a non-recurring basis. The following table presents this information as of September 30, 2011 and indicates the fair value hierarchy of the valuation techniques we utilized to determine such fair values. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities, which generally are not applicable to non-financial assets and liabilities. Fair values determined by Level 2 inputs utilize data points that are observable, such as definitive sales agreements, appraisals or established market values of comparable assets. Fair values determined by Level 3 inputs are unobservable data points for the asset or liability and include situations where there is little, if any, market activity for the asset or liability, such as internal estimates of future cash flows.


	September 30, 2011		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Long-lived assets held and used	$	20	$	—	$	20	$	—

The fair value of our long-term debt is based on quoted market prices. At September 30, 2011 and December 31, 2010, the estimated fair value of our long-term debt was approximately 101.0% and 106.3%, respectively, of the carrying value of the debt.

NOTE 15. ACQUISITIONS

During the nine months ended September 30, 2011, we acquired two diagnostic imaging centers – one in Florida and one in South Carolina, a majority interest in a diagnostic imaging center in Georgia, two oncology centers – one in Florida and one in Texas, 18 physician practice entities – the largest of which were in Florida and in North Carolina, and a majority interest in four ambulatory surgery centers – three in Texas and one in South Carolina. The aggregate purchase price of the acquisitions was $56 million, which we funded with cash on hand. We are required to allocate the purchase prices of the acquired businesses to assets acquired, liabilities assumed and, if applicable, noncontrolling interests based on their fair values. The excess of the purchase price allocation over those fair values is recorded as goodwill. We are in the process of finalizing the purchase price allocations; therefore, the fair values set forth below are subject to adjustment once the valuations are completed.


Current assets	$	4
Property and equipment		15
Other intangible assets		2
Goodwill		68
Current liabilities		(3	)
Long-term liabilities		(4	)
Redeemable noncontrolling interests in equity of consolidated subsidiaries		(16	)
Noncontrolling interests		(10	)

Net cash paid	$	56

The goodwill generated from these transactions, which we anticipate will be fully deductible for income tax purposes, can be attributed to the benefits that we expect to realize from operating efficiencies and increased reimbursement. Approximately $3 million in transaction costs related to prospective and closed acquisitions were expensed during the nine months ended September 30, 2011.

NOTE 16. RECENT ACCOUNTING STANDARDS

Changes in Accounting Principle

Effective January 1, 2011, we adopted Accounting Standard Updates (“ASU”) 2010-24, “Health Care Entities (Topic 954): Presentation of Insurance Claims and Related Insurance Recoveries,” which clarifies that a health care entity should not net insurance recoveries against a related claim liability. The adoption had no impact on our financial condition, results of operations or cash flows.

Effective January 1, 2011, we adopted ASU 2010-23, “Health Care Entities (Topic 954): Measuring Charity Care for Disclosure,” which prescribes a specific measurement basis of charity care for disclosure. The adoption had no impact on our financial condition, results of operations or cash flows.

Recently Issued Accounting Standards

In April 2011, the Financial Accounting Standards Board (“FASB”) issued ASU 2011-04, “Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs.” The guidance provided in this ASU is effective for fiscal years beginning after December 15, 2011. The adoption of this standard is not expected to have any impact on our financial condition, results of operations or cash flows.

In May 2011, the FASB issued ASU 2011-05, “Comprehensive Income (Topic 220): Presentation of Comprehensive Income,” which requires that all nonowner changes in shareholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In the two-statement approach, the first statement should present total net income and its components followed consecutively by a second statement that should

present the components of other comprehensive income and the total of comprehensive income. The guidance provided in this ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2011. The adoption of this standard is not expected to have any impact on our financial condition, results of operations or cash flows.

In July 2011, the FASB issued ASU 2011-07, “Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,” which requires health care entities to present the provision for bad debts related to patient service revenue as a deduction from patient service revenue in the statement of operations rather than as an operating expense. The guidance provided in this ASU will be effective for us beginning in the three months ending March 31, 2012. Additional disclosures relating to a company’s sources of patient revenue and its allowance for doubtful accounts related to patient accounts receivable will also be required. The adoption of this ASU is not expected to have any impact on our financial condition, overall results of operations or cash flows. Upon adoption of this ASU, we will reclassify the provision for bad debts related to prior period patient service revenue as a deduction from patient service revenue as required by this ASU.

In September 2011, the FASB issued ASU 2011-08, “Intangibles—Goodwill and Other (Topic 350): Testing Goodwill for Impairment,” which permits an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test described in Topic 350. The guidance provided in this ASU is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011. The adoption of this standard is not expected to have any impact on our financial condition, results of operations or cash flows.

Also in September 2011, the FASB issued ASU 2011-09, “Compensation—Retirement Benefits—Multiemployer Plans (Subtopic 715-80): Disclosures about an Employer’s Participation in a Multiemployer Plan,” which requires that employers provide additional separate disclosures for multiemployer pension plans and multiemployer other postretirement benefit plans. The guidance provided in this ASU will be effective for us beginning in the annual reporting period ending December 31, 2011 The adoption of this standard is not expected to have any impact on our financial condition, results of operations or cash flows.

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

INTRODUCTION TO MANAGEMENT’S DISCUSSION AND ANALYSIS

The purpose of this section, Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”), is to provide a narrative explanation of our financial statements that enables investors to better understand our business, to enhance our overall financial disclosures, to provide the context within which our financial information may be analyzed, and to provide information about the quality of, and potential variability of, our financial condition, results of operations and cash flows. Unless otherwise indicated, all financial and statistical information included herein relates to our continuing operations, with dollar amounts expressed in millions (except per share, per admission, per patient day, per adjusted patient day and per visit amounts). MD&A, which should be read in conjunction with the accompanying Condensed Consolidated Financial Statements, includes the following sections:

•

Management Overview

•

Forward-Looking Statements

•

Sources of Revenue

•

Results of Operations

•

Liquidity and Capital Resources

•

Off-Balance Sheet Arrangements

•

Critical Accounting Estimates

MANAGEMENT OVERVIEW

STRATEGY AND TRENDS

We are committed to providing the communities our hospitals and other health care facilities serve with high quality, cost-effective health care while growing our business, increasing our profitability and creating long-term value for our shareholders. We believe that our success in increasing our profitability depends in part on our success in executing the strategies and managing the trends discussed below.

Core Business Strategy—At September 30, 2011, our subsidiaries operated 49 acute care hospitals, including four academic medical centers, and one critical access hospital, with a combined total of 13,453 licensed beds, serving primarily urban and suburban communities in 11 states. Our core business is focused on providing acute care treatment, including inpatient care, intensive care, cardiac care, radiology services and emergency medical treatment, as well as outpatient services. In supporting our core business, we seek to offer superior quality and patient services, to make capital and other investments in our facilities and technology to be competitive, to recruit and retain physicians, and to negotiate favorable contracts with managed care and other commercial payers. In addition, we continually review our clinical service lines to determine which services are most highly valued and should be marketed to improve our operating results, and we strategically de-emphasize or eliminate unprofitable service lines, if appropriate.

Development Strategies—We continue to focus on opportunities to increase our outpatient revenues through organic growth and the acquisition of outpatient businesses. During the nine months ended September 30, 2011, we derived approximately 33% of our net patient revenues from outpatient services. Historically, our outpatient business has generated significantly higher margins for us than other business lines. By expanding our outpatient business, we expect to increase our profitability over time. We also intend to focus on acquiring hospitals, services providers and other health care assets and companies in markets where we believe our operating strategies can improve performance and create shareholder value. We believe that this growth by strategic acquisitions, when and if opportunities are available, can supplement the growth we believe we can generate organically in our existing markets.

Expanding Our Conifer Health Solutions Business—We intend to continue expanding our revenue cycle management, health care information management, capitation management, and patient communications services businesses under our Conifer Health Solutions (“Conifer”) subsidiary by marketing these services to non-Tenet hospitals and other health care-related entities. At September 30, 2011, Conifer provided services to more than 200 Tenet and non-Tenet hospitals and other health care organizations. We believe this business has the potential over time to generate high margins and improve our results of operations.

Commitment to Quality—Through our Commitment to Quality initiative and Medicare Performance Initiative, we continually work with physicians to implement the most current evidence-based medicine techniques to improve the way we provide care, while using labor management tools and supply chain initiatives to reduce variable costs. We believe the use of

these practices will promote the most effective and efficient utilization of resources and result in shorter lengths of stay, as well as reductions in redundant ancillary services and readmissions for hospitalized patients. As a result of our efforts, our hospitals have substantially improved in quality metrics reported by the government and have been recognized by several managed care companies for their quality of care. Leveraging off of these initiatives, we expect to benefit over time from provisions in the Patient Protection and Affordable Care Act as amended by the Health Care and Education Reconciliation Act of 2010 (“Affordable Care Act”) that tie certain payments to quality measures, establish a value-based purchasing system, and adjust hospital payment rates based on hospital-acquired conditions and hospital readmissions. In general, we believe that quality of care improvements may have the effect of reducing costs, increasing payments from Medicare and certain managed care payers for our services, and increasing physician and patient satisfaction, which may potentially improve our volumes.

Capturing HIT Incentive Payments and Other Benefits—During the nine months ended September 30, 2011, we achieved compliance with certain of the health information technology (“HIT”) requirements under the American Recovery and Reinvestment Act of 2009 (“ARRA”); as a result, we were able to recognize non-patient revenues of approximately $50 million related to Medicaid ARRA HIT incentives in 2011. These revenues, most of which we expect to receive by December 31, 2011, will partially offset the operating expenses we have incurred and continue to incur to invest in HIT systems. We also anticipate that we will be able to recognize Medicare ARRA and additional Medicaid HIT incentives in the three months ending December 31, 2011. Furthermore, we believe that the operational benefits of HIT, including improved clinical outcomes and increased operating efficiencies, will contribute to our long-term ability to grow our business.

General Economic Conditions—We believe that high unemployment rates and other adverse economic conditions are continuing to have a negative impact on our bad debt expense levels and patient volumes. However, as the economy recovers, we expect to experience improvements in these metrics relative to current levels.

Improving Operating Leverage—We are experiencing a gradual increase in patient volumes that we believe is primarily attributable to our focus on physician alignment and satisfaction, targeted capital spending on critical growth opportunities for our hospitals, emphasis on higher demand clinical service lines (including outpatient lines), the implementation of new payer contracting strategies, and improved quality metrics at our hospitals. Increases in patient volumes have been constrained by the slow pace of the current economic recovery, increased competition, utilization pressure by managed care organizations, the effects of higher patient co-pays and deductibles, and demographic trends.

Impact of Affordable Care Act—We anticipate that we will benefit over time from the provisions of the Affordable Care Act that will extend insurance coverage through Medicaid or private insurance to a broader segment of the U.S. population. Although we are unable to predict the precise impact of the Affordable Care Act on our future results of operations, and while there will be some reductions in reimbursement rates, which began in 2010, we anticipate, based on the current timetable for implementing the law, that we could begin to receive reimbursement for caring for uninsured and underinsured patients as early as 2014. We believe we are well-positioned relative to other health care companies to benefit from extended insurance coverage given the concentration of our operations in California, Florida and Texas, which states historically have higher percentages of uninsured and underinsured patients compared to the national average.

Our ability to execute on these strategies and manage these trends is subject to a number of risks and uncertainties that may cause actual results to be materially different from expectations. For information about these risks and uncertainties, see the Forward-Looking Statements and Risk Factors sections in Part I of our Annual Report on Form 10-K for the year ended December 31, 2010 (“Annual Report”).

RESULTS OF OPERATIONS—OVERVIEW

Our results of operations have been and continue to be influenced by industry-wide and company-specific challenges, including constrained volume growth, decreased demand for inpatient cardiac procedures and high levels of bad debt, that have affected our revenue growth and operating expenses. We have provided in the tables below information relating to volumes, revenues and expenses for the three months ended September 30, 2011 and 2010 for all of our continuing operations hospitals.


	Three Months Ended September 30,
Admissions, Patient Days and Surgeries	2011			2010			Increase (Decrease)
Total admissions		127,520			125,645			1.5	%
Paying admissions (excludes charity and uninsured)		118,505			116,672			1.6	%
Charity and uninsured admissions		9,015			8,973			0.5	%
Admissions through emergency department		75,624			72,914			3.7	%
Paying admissions as a percentage of total admissions		92.9	%		92.9	%		—	(1)
Charity and uninsured admissions as a percentage of total admissions		7.1	%		7.1	%		—	(1)
Emergency department admissions as a percentage of total admissions		59.3	%		58.0	%		1.3	(1)
Surgeries – inpatient		37,721			37,916			(0.5	)%
Surgeries – outpatient		56,222			53,148			5.8	%
Total surgeries		93,943			91,064			3.2	%
Patient days – total		601,915			596,810			0.9	%
Adjusted patient days(2)		925,165			913,049			1.3	%
Average length of stay (days)		4.7			4.7			—	%
Adjusted patient admissions(2)		198,110			193,670			2.3	%

(1)	The change is the difference between the amounts shown for the three months ended September 30, 2011 as compared to the three months ended September 30, 2010.

(2)	Adjusted patient days/admissions represents actual patient days/admissions adjusted to include outpatient services by multiplying actual patient days/admissions by the sum of gross inpatient revenues and outpatient revenues and dividing the results by gross inpatient revenues.

Total admissions increased by 1,875, or 1.5%, in the three months ended September 30, 2011 as compared to the same period in 2010. Three of our four regions reported admissions increases in the three months ended September 30, 2011 as compared to the three months ended September 30, 2010. Total surgeries increased by 3.2% in the three months ended September 30, 2011 as compared to the same period in 2010. While our emergency department admissions increased 3.7% in the three months ended September 30, 2011 compared to the same period in the prior year, we believe the current economic conditions continue to have an adverse impact on the level of elective procedures performed at our hospitals, which constrained the overall change in our total admissions.


	Three Months Ended September 30,
Outpatient Visits	2011			2010			Increase (Decrease)
Total visits		1,009,936			976,310			3.4	%
Paying visits (excludes charity and uninsured)		901,695			871,930			3.4	%
Charity visits and uninsured visits		108,241			104,380			3.7	%
Emergency department visits		373,295			359,658			3.8	%
Surgery visits		56,222			53,148			5.8	%
Paying visits as a percentage of total visits		89.3	%		89.3	%		—	(1)
Charity visits and uninsured visits as a percentage of total visits		10.7	%		10.7	%		—	(1)

(1)	The change is the difference between the amounts shown for the three months ended September 30, 2011 as compared to the three months ended September 30, 2010.

We had an increase of 33,626 total outpatient visits, or 3.4%, in the three months ended September 30, 2011 as compared to the three months ended September 30, 2010. Three of our four regions reported increased outpatient visits in the three months ended September 30, 2011, with the strongest improvement occurring in our Florida region. The increase in Florida region visits is attributable to the various outpatient centers we acquired in Florida in September 2010.

Outpatient surgery visits increased by 5.8% in the three months ended September 30, 2011 as compared to the same period in 2010. Charity and uninsured outpatient visits increased by 3.7% in the three months ended September 30, 2011 compared to the three months ended September 30, 2010.


	Three Months Ended September 30,
Revenues	2011		2010		Increase (Decrease)
Net operating revenues	$	2,342	$	2,262		3.5	%
Revenues from the uninsured	$	161	$	163		(1.2	)%
Net inpatient revenues(1)	$	1,477	$	1,430		3.3	%
Net outpatient revenues(1)	$	749	$	734		2.0	%

(1)

Net inpatient revenues and net outpatient revenues are components of net operating revenues. Net inpatient revenues include self-pay revenues of $69 million and $63 million for the three months ended September 30, 2011 and 2010, respectively. Net outpatient revenues include self-pay revenues of $92 million and $100 million for the three months ended September 30, 2011 and 2010, respectively.

Net operating revenues increased by $80 million, or 3.5%, for the three months ended September 30, 2011 as compared to the same period in 2010. Net operating revenues in the three months ended September 30, 2011 included (i) a $4 million increase in Medicaid disproportionate share hospital (“DSH”) revenues and other state-funded subsidy payments in the 2011 period compared to the same period in 2010, and (ii) recognition by our Philadelphia hospitals of $6 million of revenues that were approved for distribution to us in the three months ended September 30, 2011 by a Philadelphia health maintenance organization (“HMO”) in which we hold a minority interest.

In addition to certain of the factors discussed above, net patient revenues increased by 2.9% in the three months ended September 30, 2011 as compared to the same period in 2010, primarily as a result of managed care pricing improvement, a favorable shift in managed care payer mix, and an increase in total outpatient visits of 3.4%.


	Three Months Ended September 30,
Revenues on a Per Admission, Per Patient Day and Per Visit Basis	2011		2010		Increase (Decrease)
Net inpatient revenue per admission	$	11,582	$	11,381		1.8	%
Net inpatient revenue per patient day	$	2,454	$	2,396		2.4	%
Net outpatient revenue per visit	$	742	$	752		(1.3	)%
Net patient revenue per adjusted patient admission(1)	$	11,236	$	11,174		0.6	%
Net patient revenue per adjusted patient day(1)	$	2,406	$	2,370		1.5	%

(1)	Adjusted patient days/admissions represents actual patient days/admissions adjusted to include outpatient services by multiplying actual patient days/admissions by the sum of gross inpatient revenues and outpatient revenues and dividing the results by gross inpatient revenues.

Inpatient unit revenue improvement was evident across all key metrics, primarily reflecting the improved terms of our managed care contracts in the three months ended September 30, 2011 compared to the same period in 2010. The decline in net outpatient revenue per visit was primarily due to the provision of lower acuity services by outpatient centers we acquired in 2010 and 2011, as well as an unfavorable shift in our total outpatient payer mix, including a decline in commercial managed care outpatient visits as a percentage of total outpatient visits in the three months ended September 30, 2011 as compared to the same period in 2010.


	Three Months Ended September 30,
Selected Operating Expenses	2011		2010		Increase (Decrease)
Salaries, wages and benefits	$	1,019	$	977		4.3	%
Supplies		388		390		(0.5	)%
Other operating expenses		547		505		8.3	%

Total	$	1,954	$	1,872		4.4	%
Rent/lease expense(1)	$	37	$	35		5.7	%
Salaries, wages and benefits per adjusted patient day(2)	$	1,102	$	1,070		3.0	%
Supplies per adjusted patient day(2)		419		427		(1.9	)%
Other operating expenses per adjusted patient day(2)		591		553		6.9	%

Total per adjusted patient day	$	2,112	$	2,050		3.0	%

(1)	Included in other operating expenses.

(2)	Adjusted patient days represent actual patient days adjusted to include outpatient services by multiplying actual patient days by the sum of gross inpatient revenues and outpatient revenues and dividing the results by gross inpatient revenues.

Total selected operating expenses, which is defined as salaries, wages and benefits, supplies and other operating expenses, increased by 3.0% on a per adjusted patient day basis in the three months ended September 30, 2011 compared to the three months ended September 30, 2010.

Salaries, wages and benefits per adjusted patient day increased by 3.0% in the three months ended September 30, 2011 as compared to the same period in 2010. This increase is primarily due to annual merit increases for our employees, as well as an increase in the number of physicians we employ, increased overtime costs and increased employee-related costs associated with our HIT implementation program, partially offset by reductions in workers’ compensation expense and annual incentive compensation expense. Workers’ compensation expense in the 2011 period includes $3 million of expense due to a 107 basis point decrease in the interest rate used to estimate the discounted present value of projected future workers’ compensation liabilities.

Supplies expense per adjusted patient day decreased by 1.9% in the three months ended September 30, 2011 compared to the three months ended September 30, 2010. Supplies expense was favorably impacted by a decline in orthopedic and cardiology-related costs due to renegotiated prices and lower volume levels, partially offset by increased costs of surgical supplies. In general, supplies expense changes are primarily attributable to changes in our patient volume levels and the mix of procedures performed.

Other operating expenses per adjusted patient day increased by 6.9% in the three months ended September 30, 2011 as compared to the same period in 2010. This change is primarily due to increased physician and medical fees, higher malpractice expense, increased costs of contracted services, increased systems implementation costs and information technology service contract expenses primarily related to our HIT implementation program, increased physician relocation and income guarantee costs, and increased repairs and maintenance expense. Malpractice expense in the 2011 period includes $13 million of expense due to a 107 basis point decrease in the interest rate used to estimate the discounted present value of projected future malpractice liabilities, partially offset by improved claims experience trends.


	Three Months Ended September 30,
Provision for Doubtful Accounts	2011			2010			Increase (Decrease)
Provision for doubtful accounts	$	193		$	187			3.2	%
Provision for doubtful accounts as a percentage of net operating revenues		8.2	%		8.3	%		(0.1	)(1)
Collection rate on self-pay accounts(2)		27.7	%		29.1	%		(1.4	)(1)
Collection rate on commercial managed care accounts		98.4	%		98.3	%		0.1	(1)

(1)	The change is the difference between the amounts shown for the three months ended September 30, 2011 as compared to the three months ended September 30, 2010.

(2)	Self-pay accounts receivable are comprised of both uninsured and balance-after insurance receivables.

Provision for doubtful accounts increased by $6 million, or 3.2%, in the three months ended September 30, 2011 as compared to the same period in 2010. The increase in provision for doubtful accounts primarily related to a $9 million favorable adjustment in the 2010 period for Medicare bad debts to be claimed on our cost reports compared to $2 million in the 2011 period, as well as the impact of a 140 basis point decline in our collection rate on self-pay accounts. Our self-pay collection rate, which is the blended collection rate for uninsured and balance-after insurance accounts receivable, declined to approximately 27.7% as of September 30, 2011 from 29.1% as of September 30, 2010.

The estimated direct and allocated costs (based on selected operating expenses, which include salaries, wages and benefits, supplies and other operating expenses) of caring for uninsured patients were $105 million and $97 million in the three months ended September 30, 2011 and 2010, respectively.

The table below shows the pre-tax and after-tax impact on continuing operations for the three months ended September 30, 2011 and 2010 of the following items:


	Three Months Ended September 30,						Nine Months Ended September 30,
	2011			2010			2011			2010
	(Expense) Income
Impairment of long-lived assets and goodwill, and restructuring charges	$	(8	)	$	(3	)	$	(18	)	$	(1	)
Litigation and investigation costs		(5	)		(2	)		(24	)		(6	)
Loss from early extinguishment of debt		—			(55	)		—			(55	)

Pre-tax impact	$	(13	)	$	(60	)	$	(42	)	$	(62	)
Deferred tax asset valuation allowance and other tax adjustments	$	4		$	981		$	16		$	1,020
Total after-tax impact	$	(4	)	$	946		$	(10	)	$	984
Diluted per-share impact of above items	$	(0.01	)	$	1.69		$	(0.02	)	$	1.76
Diluted earnings per share, including above items	$	0.02		$	1.68		$	0.26		$	1.91

LIQUIDITY AND CAPITAL RESOURCES OVERVIEW

Cash and cash equivalents were $185 million at September 30, 2011, a decrease of $79 million from $264 million at June 30, 2011.

Significant cash flow items in the three months ended September 30, 2011 included:

•

Net cash receipts of $12 million related to the California and Pennsylvania hospital fee programs, as described in “Sources of Revenue” below;

•

$18 million of collections related to state Medicaid ARRA HIT incentives;

•

Sales proceeds of $17 million related to the sale of land and buildings;

•

Capital expenditures of $100 million;

•

Preferred stock dividend payments of $6 million;

•

Income tax payments of $11 million;

•

Payments on reserves for restructuring charges and litigation costs of $6 million;

•

Interest payments of $73 million;

•

$14 million of payments to acquire various outpatient and physician practice businesses;

•

$124 million of payments to repurchase common stock; and

•

A payment of approximately $13 million for the settlement of two Hurricane Katrina-related class action lawsuits.

Net cash provided by operating activities was $324 million in the nine months ended September 30, 2011 compared to $297 million in the nine months ended September 30, 2010. Key positive and negative factors contributing to the change between the 2011 and 2010 periods include the following:

•

Increased income from continuing operations before income taxes of $82 million, excluding investment earnings, loss from early extinguishment of debt, interest expense, litigation and investigation costs, impairment and restructuring charges, and depreciation and amortization, in the nine months ended September 30, 2011 compared to the nine months ended September 30, 2010;

•

Lower interest payments of $58 million (our interest rate swap agreement generated approximately $8 million of cash interest savings and $22 million proceeds from the termination of the agreement);

•

Reduced cash flows associated with various changes in working capital and changes in long-term liabilities, including the following:

•

$7 million of Medicaid DSH and other state-funded subsidy revenues related to Pennsylvania’s Medical Assistance program recognized in the nine months ended September 30, 2011 that are expected to be collected later in 2011;

•

a $32 million receivable recorded in the nine months ended September 30, 2011 that is expected to be collected later in 2011 related to state Medicaid ARRA HIT incentives;

•

a $6 million receivable recorded in the nine months ended September 30, 2011 related to the estimated recovery of the employer portion of certain payroll taxes paid by us prior to April 2005 on behalf of medical residents that we expect will be refunded to us in 2012; and

•

$91 million of reduced net cash flows in the 2011 period compared to the 2010 period related to accounts receivable primarily due to payment delays by certain government payers and a temporary delay in the adjudication of accounts receivable due to processing changes we implemented to capture long-term operating efficiencies;

•

Income tax refunds of $9 million in the nine months ended September 30, 2011 compared to $34 million in the nine months ended September 30, 2010;

•

Lower aggregate annual 401(k) matching contributions and annual incentive compensation payments of $20 million ($85 million in the nine months ended September 30, 2011 compared to $105 million in the nine months ended September 30, 2010);

•

Lower payments on reserves for restructuring charges and litigation costs of $49 million; and

•

$39 million of additional cash used in operating activities from discontinued operations (including approximately $13 million in payments relating to the settlement of two class action lawsuits resulting from Hurricane Katrina).

FORWARD-LOOKING STATEMENTS

The information in this report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. All statements, other than statements of historical or present facts, that address activities, events, outcomes, business strategies and other matters that we plan, expect, intend, assume, believe, budget, predict, forecast, project, estimate or anticipate (and other similar expressions) will, should or may occur in the future are forward-looking statements. These forward-looking statements represent management’s current belief, based on currently available information, as to the outcome and timing of future events. They involve known and unknown risks, uncertainties and other factors – many of which we are unable to predict or control – that may cause our actual results, performance or achievements, or health care industry results, to be materially different from those expressed or implied by forward-looking statements. Such factors include, but are not limited to, the risks described in the Forward-Looking Statements and Risk Factors sections in Part I of our Annual Report.

When considering forward-looking statements, a reader should keep in mind the risk factors and other cautionary statements in our Annual Report and in this report. Should one or more of the risks and uncertainties described in our Annual Report or this report occur, or should underlying assumptions prove incorrect, our actual results and plans could differ materially from those expressed in any forward-looking statements. We specifically disclaim any obligation to update any information contained in a forward-looking statement or any forward-looking statement in its entirety and, therefore, disclaim any resulting liability for potentially related damages.

All forward-looking statements attributable to us are expressly qualified in their entirety by this cautionary statement.

SOURCES OF REVENUE

We receive revenues for patient services from a variety of sources, primarily managed care payers and the federal Medicare program, as well as state Medicaid programs, indemnity-based health insurance companies and self-pay patients (that is, patients who do not have health insurance and are not covered by some other form of third-party arrangement).

The table below shows the sources of net patient revenues for our general hospitals, expressed as percentages of net patient revenues from all sources:


	Three Months Ended September 30,									Nine Months Ended September 30,
Net Patient Revenues from:	2011			2010			Increase (Decrease)(1)			2011			2010			Increase (Decrease)(1)
Medicare		22.7	%		23.7	%		(1.0	)		23.2	%		24.0	%		(0.8	)
Medicaid		8.0	%		8.0	%		—			9.1	%		8.7	%		0.4
Managed care		58.0	%		57.0	%		1.0			56.8	%		56.2	%		0.6
Indemnity, self-pay and other		11.3	%		11.3	%		—			10.9	%		11.1	%		(0.2	)

(1)	The increase (decrease) is the difference between the 2011 and 2010 percentages shown.

Our payer mix on an admissions basis for our general hospitals, expressed as a percentage of total admissions from all sources, is shown below:


	Three Months Ended September 30,									Nine Months Ended September 30,
Admissions from:	2011			2010			Increase (Decrease)(1)			2011			2010			Increase (Decrease)(1)
Medicare		28.5	%		28.9	%		(0.4	)		29.7	%		30.0	%		(0.3	)
Medicaid		13.3	%		13.4	%		(0.1	)		12.9	%		13.0	%		(0.1	)
Managed care		48.0	%		47.7	%		0.3			47.5	%		47.5	%		—
Indemnity, self-pay and other		10.2	%		10.0	%		0.2			9.9	%		9.5	%		0.4

(1)	The increase (decrease) is the difference between the 2011 and 2010 percentages shown.

GOVERNMENT PROGRAMS

The Medicare program, the nation’s largest health insurance program, is administered by the Centers for Medicare and Medicaid Services (“CMS”) of the U.S. Department of Health and Human Services (“HHS”). Medicare is a health insurance program primarily for individuals 65 years of age and older, certain younger people with disabilities, and people with end-stage renal disease, and is provided without regard to income or assets. Medicaid is a program that pays for medical assistance for certain individuals and families with low incomes and resources, and is jointly funded by the federal government and state governments. Medicaid is the largest source of funding for medical and health-related services for the nation’s poor and most vulnerable individuals.

In addition to the changes affected by the Affordable Care Act, as described in our Annual Report, the Medicare and Medicaid programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations, requirements for utilization review, and federal and state funding restrictions, all of which could materially increase or decrease payments from these government programs in the future, as well as affect the cost of providing services to our patients and the timing of payments to our facilities. We are unable to predict the effect of future government health care funding policy changes on our operations. If the rates paid by governmental payers are reduced, if the scope of services covered by governmental payers is limited, or if we or one or more of our subsidiaries’ hospitals are excluded from participation in the Medicare or Medicaid program or any other government health care program, there could be a material adverse effect on our business, financial condition, results of operations or cash flows.

Medicare

Medicare offers its beneficiaries different ways to obtain their medical benefits. One option, the Original Medicare Plan, is a fee-for-service payment system. The other option, called Medicare Advantage, includes HMOs, preferred provider

organizations (“PPOs”), private fee-for-service Medicare special needs plans and Medicare medical savings account plans. The major components of our net patient revenues for hospital services provided to patients enrolled in the Original Medicare Plan for the three and nine months ended September 30, 2011 and 2010 are set forth in the following table:


	Three Months Ended September 30,					Nine Months Ended September 30,
Revenue Descriptions	2011			2010		2011			2010
Medicare severity-adjusted diagnosis-related group – operating	$	270		$	273	$	865		$	885
Medicare severity-adjusted diagnosis-related group – capital		25			25		78			81
Outliers		12			11		35			38
Outpatient		118			113		354			342
Disproportionate share		53			53		162			163
Direct Graduate and Indirect Medical Education(1)		28			30		83			85
Other(2)		15			15		47			36
Adjustments for prior-year cost reports and related valuation allowances		(3	)		2		(1	)		(12	)

Total Medicare net patient revenues	$	518		$	522	$	1,623		$	1,618

(1)	Includes Indirect Medical Education revenue earned by our children’s hospital under the Children’s Hospitals Graduate Medical Education Payment Program administered by the Health Resources and Services Administration of HHS.

(2)	The other revenue category includes inpatient psychiatric units, inpatient rehabilitation units, one long-term acute care hospital, other revenue adjustments, and adjustments related to the estimates for current-year cost reports and related valuation allowances.

Medicaid

Medicaid programs and the corresponding reimbursement methodologies are administered by the states and vary from state to state and from year to year. Estimated revenues under various state Medicaid programs, excluding state-funded managed care Medicaid programs, constituted approximately 9.1% and 8.7% of net patient revenues at our continuing general hospitals for the nine months ended September 30, 2011 and 2010, respectively. We also receive DSH payments under various state Medicaid programs. For the nine months ended September 30, 2011 and 2010, our revenues attributable to DSH payments and other state-funded subsidy payments were approximately $199 million and $134 million, respectively, with the 2011 amount including the California and Pennsylvania revenue amounts discussed below of $63 million and $32 million, respectively.

Several states in which we operate have recently faced budgetary challenges that resulted in reduced Medicaid funding levels to hospitals and other providers. Because most states must operate with balanced budgets, and the Medicaid program is generally a significant portion of a state’s budget, states can be expected to adopt or consider adopting future legislation designed to reduce their Medicaid expenditures. The recent economic downturn has increased budget pressures on most states, and these budget pressures have resulted, and likely will continue to result, in decreased spending for Medicaid programs in many states. Most states began a new fiscal year on July 1, 2011 and, although most addressed projected shortfalls in their final budgets, some states are still facing budget gaps. Increased Medicaid enrollment due to the economic downturn, limits on the ability of states to reduce Medicaid eligibility criteria enacted as part of the Affordable Care Act, budget gaps and other factors could result in future reductions to Medicaid payments or additional taxes on hospitals. Some states are considering proposals that would result in such reductions.

As an alternative means of funding provider payments, several states in which we operate have adopted or are considering adopting broad-based provider taxes to fund the non-federal share of Medicaid programs. Some states, such as California and Pennsylvania, as described below, have introduced provider fee arrangements, which are intended to enhance funding or partially mitigate reduced Medicaid funding levels to hospitals and other providers.

Because we cannot predict what actions the federal government or the states may take under existing legislation and future legislation to address budget gaps or deficits, we are unable to assess the effect that any such legislation might have on our business, but the impact on our future financial position, results of operations or cash flows could be material.

Medicaid-related patient revenues recognized by our continuing general hospitals from Medicaid-related programs in the states in which they are located, as well as from Medicaid programs in neighboring states, for the nine months ended September 30, 2011 and 2010 are set forth in the table below:


	Nine Months Ended September 30,
	2011				2010
Hospital Location	Medicaid		Managed Medicaid		Medicaid		Managed Medicaid
California	$	159	$	91	$	102	$	80
Florida		141		45		147		41
Pennsylvania		74		138		37		118
Georgia		70		31		67		29
Texas		51		88		47		81
Missouri		38		4		61		4
South Carolina		28		17		47		16
Alabama		22		—		20		—
North Carolina		18		—		21		—
Nebraska		15		5		18		4
Tennessee		8		23		8		21

	$	624	$	442	$	575	$	394

In October 2009, the Governor of California signed legislation supported by the hospital industry to impose a provider fee on general acute care hospitals that, combined with federal matching funds, would be used to provide supplemental Medi-Cal payments to hospitals, as well as provide the state with $320 million annually for children’s health care coverage, for the 21-month period retroactive to April 2009 and expiring on December 31, 2010 (the “21-Month Program”). The state submitted the plan to CMS for required review and approval and, on October 7, 2010, CMS approved the fee-for-service portion of the 21-Month Program. On January 18, 2011, CMS issued the final required federal approval of the program, which allowed us to recognize $63 million of additional revenues, net of provider fees and other expenses, during the three months ended March 31, 2011. We made $5 million of our required payments and received approximately $59 million in additional supplemental proceeds during 2011 related to the 21-Month Program.

On April 13, 2011, the Governor of California signed legislation that created a fee program to provide supplemental Medi-Cal payments to hospitals retroactive to January 1, 2011 and expiring on June 30, 2011 (the “Six-Month Program”). Based on the most recent California Hospital Association model, the Six-Month Program could result in approximately $26 million of net revenues for our California hospitals in 2011. Similar to the 21-Month Program, CMS approval is required before the Six-Month Program may be implemented. On May 18, 2011, CMS approved certain elements of the Six-Month Program that enabled the state to commence collecting provider fees and making supplemental fee-for-service payments; however, as of September 30, 2011, CMS had not yet issued the final required approval of the Six-Month Program. Accordingly, we will recognize the additional revenues for our hospitals, net of provider fees and other expenses, in the period CMS issues final approval of the Six-Month Program. We have made $44 million of our required payments and received approximately $56 million in additional supplemental proceeds during 2011 related to the Six-Month Program. The net $12 million of supplemental proceeds received in excess of fees paid during 2011 is considered deferred income. We cannot provide any assurances regarding the final approval of the Six-Month Program by CMS or the timing or amount of the payments we may ultimately receive or be required to make.

On September 16, 2011, the Governor of California signed legislation, similar to the 21-Month Program and Six-Month Program described above, to impose a provider fee on hospitals and provide supplemental payments to hospitals for the 30-month period from July 1, 2011 through December 31, 2013 (the “30-Month Program”). CMS has not issued any approvals in connection with the 30-Month Program. Based on the most recent California Hospital Association model, the 30-Month Program could result in approximately $210 million of net revenues for our California hospitals. We expect to record the additional net revenues, net of provider fees and other expenses, ratably over 30 months retroactive to July 2011 beginning in the period CMS issues the required approvals of the 30-Month Program. We cannot provide any assurances regarding the final approval of the 30-Month Program by CMS or the timing or amount of the payments we may ultimately receive or be required to make.

During the three months ended March 31, 2011, CMS issued final approval of Pennsylvania’s Medical Assistance payment system, which includes, among other things, a three-year provider fee program for the period July 1, 2010 through June 30, 2013. Based on estimates prepared by the Hospital Association of Pennsylvania, this program is expected to result in

approximately $26 million of additional net revenues for our Pennsylvania hospitals in the state fiscal year 2011 (July 1, 2010-June 30, 2011) and approximately $24 million of additional net revenues for our Pennsylvania hospitals in the state fiscal year 2012 (July 1, 2011-June 30, 2012). Net operating revenues in the nine months ended September 30, 2011 included approximately $32 million related to the program, of which the portion related to the year ended December 31, 2010 was approximately $13 million.

In March 2011, the State of Georgia adopted an amended budget for the state fiscal year ended June 30, 2011 that included additional funding for payments to private hospitals from the Indigent Care Trust Fund (“ICTF”), the state’s disproportionate share program. During the six months ended June 30, 2011, we received payments to our hospitals from the ICTF of approximately $13 million, of which $10 million was recognized in the three months ended March 31, 2011, and the portion related to 2010 was approximately $7 million. During the three months ended June 30, 2010, we recognized $11 million of ICTF funds because such funding in 2010 was approved by the State of Georgia in the three months ended June 30, 2010.

Based on a recent audit of Missouri’s 2005-2007 Medicaid plan years, it was determined that excess DSH payments were made to hospitals and that excess payments were likely in 2011. Effective June 1, 2011, the State of Missouri Department of Social Services Medicaid Division implemented an emergency rule that allows it to recoup state fiscal year 2011 (July 2010 - June 2011) DSH payments from hospitals with DSH “longfalls” (i.e., payments in excess of costs) and redistribute the funds to hospitals with DSH “shortfalls” (i.e., payments lower than costs). The state implemented this rule on an emergency basis as it allows the state to redistribute DSH payments to hospitals in accordance with CMS audit requirements. In September 2011, the state issued notices of the estimated overpayments to the affected hospitals. Based on these notices, the estimated amount that we have to repay as a result of this emergency rule is approximately $12 million. We are currently challenging the recoupment and redistribution; however, we cannot predict the outcome of such action. Accordingly, as of September 30, 2011, we have recorded a liability of approximately $12 million for this matter.

Regulatory and Legislative Changes

Material updates to the information set forth in our Annual Report about the Medicare and Medicaid programs are provided below.

Payment and Policy Changes to the Medicare Inpatient Prospective Payment System

Under Medicare law, CMS is required annually to update certain rules governing the inpatient prospective payment system (“IPPS”). The updates generally become effective October 1, the beginning of the federal fiscal year (“FFY”). On August 1, 2011, CMS issued the Changes to the Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and Fiscal Year 2012 Rates (“Final Rule”). The Final Rule includes the following payment and policy changes:

•

A market basket increase of 3.0% for Medicare severity-adjusted diagnosis-related group (“MS-DRG”) operating payments for hospitals reporting specified quality measure data (hospitals that do not report specified quality measure data will receive an increase of 1.0%); CMS also made certain adjustments to the estimated 3.0% market basket increase that will result in a net market basket update of 1.0%, including the following adjustments to the market basket index:

•

Market basket index and productivity reductions required by the Affordable Care Act of 0.10% and 1.0%, respectively;

•

A reduction of 2.0% to permanently remove approximately one half of the estimated 3.9% documentation and coding adjustment resulting from the conversion to MS-DRGs; CMS did not indicate when it will remove the remaining 1.9%; however, CMS did indicate that it is feasible that all or most of the adjustment could be made in FFY 2013; and

•

An increase of 1.1% to prospectively correct an error in the standardized rate related to the rural floor budget neutrality adjustment that occurred in prior years;

•

A 0.34% net increase in the capital federal MS-DRG rate; and

•

A decrease in the cost outlier threshold from $23,075 to $22,385.

The Final Rule also adopts for FFY 2014 a measure relating to Medicare spending per beneficiary for both the Hospital Inpatient Quality Reporting Program and the new Hospital Inpatient Value-Based Purchasing program required by the Affordable Care Act. The new measure will assess Part A and Part B beneficiary spending during a period of time that spans from three days prior to a hospital admission through 30 days after the patient is discharged. The goal is to encourage hospitals to provide high-quality care to Medicare beneficiaries at a lower cost and to promote greater efficiencies, including measures to reduce unnecessary hospital readmissions across patient care settings throughout the entire U.S. health care system.

CMS projects that the combined impact of the payment and policy changes will yield an average 1.2% increase in payments for hospitals in large urban areas (populations over one million). Using the impact percentages in the Final Rule as applied to our IPPS payments for the 12 months ended September 30, 2011, the estimated annual impact for all changes in the Final Rule on our hospitals is an increase in our Medicare inpatient revenues of approximately $16 million. Because of the uncertainty associated with various factors that may influence our future IPPS payments by individual hospital, including admission volumes, length of stay and case mix, we cannot provide any assurances regarding this estimate.

Payment Changes to the Medicare Inpatient Rehabilitation Facility Prospective Payment System

On July 29, 2011, CMS issued a final rule that implements certain provisions of the Affordable Care Act and updates the prospective payment rates for the Medicare inpatient rehabilitation facility (“IRF”) prospective payment system (“PPS”) for FFY 2012 (“IRF-PPS Final Rule”). The IRF-PPS Final Rule, as subsequently corrected on September 26, 2011, includes the following payment changes:

•

A net payment increase for IRFs of 1.8%, which reflects a market basket index increase of 2.9%, reduced by a productivity adjustment of 1.0% and an additional 0.1%, both as required by the Affordable Care Act, as well as other adjustments, including a budget neutrality reduction; and

•

A decrease in the outlier threshold for high cost outlier cases from $11,410 to $10,713.

The IRF-PPS Final Rule also implements Section 3004 of the Affordable Care Act, which establishes a new quality reporting program that provides for a 2% reduction in the annual IRF-PPS increase factor beginning in 2014 for IRFs that fail to report quality data.

At September 30, 2011, eight of our general hospitals operated inpatient rehabilitation units. CMS projects that the payment changes in the IRF-PPS Final Rule will result in an estimated total increase in aggregate IRF payments of 2.2%. This estimated increase includes an average 2.3% increase for rehabilitation units in hospitals located in urban areas for FFY 2012. Using the urban rehabilitation unit impact percentage as applied to our Medicare IRF payments for the 12 months ended September 30, 2011, the annual impact of the payment changes in the IRF-PPS Final Rule may result in an estimated increase in our Medicare revenues of less than $1 million. Because of the uncertainty of the factors that may influence our future IRF payments, including legislative action, admission volumes, length of stay and case mix, and the impact of compliance with IRF admission criteria, we cannot provide any assurances regarding our estimate of the impact of these changes.

Payment Changes to the Medicare Inpatient Psychiatric Facility Prospective Payment System

On April 28, 2011, CMS issued a final rule updating the prospective payment rates for the Medicare inpatient psychiatric facility (“IPF”) PPS for the rate year beginning July 1, 2011 (“IPF-PPS Final Rule”). The IPF-PPS Final Rule includes the following payment and policy changes:

•

A change to the IPF-PPS rate update period to a rate year that coincides with the FFY effective October 1, 2011 that will apply to discharges beginning July 1, 2011 through September 30, 2012; and

•

An update to IPF-PPS payments equal to the market basket of 3.2% for the 15-month rate year period minus a 0.25% reduction required by the Affordable Care Act and a 0.21% reduction due to an update of the fixed dollar loss threshold.

At September 30, 2011, 11 of our general hospitals operated inpatient psychiatric units reimbursed under the IPF-PPS. CMS projects that the combined impact of the payment and policy changes included in the IPF-PPS Final Rule will yield an average 2.74% increase in payments for all IPFs (including psychiatric units in acute care hospitals) and an average 2.43% increase in payments for psychiatric units of acute care hospitals located in urban areas for the 15-month rate period beginning July 1, 2011. Using the urban psychiatric unit impact percentage as applied to our IPF-PPS payments for the 12 months ended June 30, 2011, the annual impact of all payment and policy changes in the IPF-PPS Final Rule on our IPF-PPS psychiatric units

may result in an estimated increase in our Medicare revenues of approximately $1 million. Because of the factors that may influence our future IPF-PPS payments, including future legislation, admission volumes, length of stay and case mix, we cannot provide any assurances regarding our estimate of the impact of the aforementioned changes.

Proposed Payment and Policy Changes to the Medicare Outpatient Prospective Payment System

On July 1, 2011, CMS released the Proposed Changes to the Hospital Outpatient Prospective Payment System (“OPPS”) and Calendar Year (“CY”) 2012 Payment Rates (“Proposed OPPS Rule”). The Proposed OPPS Rule includes the following payment and policy changes:

•

A net update to OPPS payments equal to the estimated market basket of 1.5%, which takes into account a projected hospital OPPS market basket percentage increase of 2.8%, minus an estimated productivity adjustment of 1.2% and a 0.1% adjustment, both of which are necessary to comply with certain provisions of the Affordable Care Act;

•

A budget neutrality reduction of 0.7% in payments for non-cancer OPPS hospitals to fund an increase in OPPS payments to cancer hospitals mandated under the Affordable Care Act; and

•

The addition of nine quality measures to the current list of 23 outpatient measures that hospitals would have to report for determining CY 2014 payments.

CMS projects that the combined impact of the payment and policy changes in the Proposed OPPS Rule will yield an average 1.1% increase in payments for all hospitals and an average 1.1% increase in payments for hospitals in large urban areas (populations over one million). According to CMS’ estimates, the projected annual impact of the payment and policy changes in the Proposed OPPS Rule on our hospitals is a $4 million increase in our Medicare outpatient revenues. Because of the uncertainty associated with the proposals and other factors that may influence our future OPPS payments by individual hospital, including patient volumes and case mix, we cannot provide any assurances regarding this estimate.

Proposed Changes to the Medicare Physician Fee Schedule

On July 1, 2011, CMS published a proposed regulation detailing Medicare physician payment policies for 2012. The rule confirms that, unless Congress intervenes, under current law Medicare’s physician payments will decrease in January 2012 by 29.5%. This change could reduce our annual net revenues for services paid to our physicians and freestanding diagnostic imaging centers under the Medicare Physician Fee Schedule (“MPFS”) by approximately $10 million. In addition, a reduction of this magnitude could result in some physicians reducing or eliminating the number of Medicare beneficiaries they treat. Historically, Congress has intervened to forestall these statutory reductions to the MPFS; however, permanently mitigating the reduction under the federal budget neutrality rules would require an offset achieved by tax increases or reduced spending in other areas, such as Medicare payments to hospitals. We cannot predict what action, if any, Congress will take with respect to this matter.

Medicare Value-Based Purchasing

Section 3001 of the Affordable Care Act requires the Secretary of HHS to establish a value-based purchasing (“VBP”) program for hospital payments beginning in FFY 2013 based on hospital performance measures that are part of the hospital inpatient quality reporting program. The VBP program is intended to be budget-neutral, with 1% of IPPS payments allocated to the program in FFY 2013 and increasing over time to 2% in FFY 2017 and beyond. On April 29, 2011, CMS issued the final rule establishing the hospital VBP program under the Medicare IPPS. Under the hospital VBP program, CMS will evaluate hospitals’ performance during the period July 1, 2011 through March 31, 2012 for the FFY 2013 hospital VBP payment determination. Hospitals will receive points on each measure based on the higher of their level of (1) achievement relative to an established standard based on all other hospitals’ baseline period performance, or (2) improvement in performance from their performance during a prior baseline period. The combined scores on all the measures will be translated into value-based incentive payments for discharges occurring on or after October 1, 2012. CMS will notify each hospital of the estimated amount of its value-based incentive payment for FFY 2013 at least 60 days prior to October 1, 2012 and will notify each hospital of the exact amount of its value-based incentive payment on November 1, 2012. Although we believe that our Commitment to Quality initiatives will position our hospitals to benefit under the VBP program, we cannot predict with certainty the impact of the VBP program on our results of operations or cash flows.

Medicaid Electronic Health Record Incentive Payments

The Medicaid Electronic Health Record (“EHR”) Incentive Program provides incentive payments to eligible hospitals, physicians and certain other professionals (“Providers”) as they adopt, implement, upgrade or demonstrate meaningful use of certified EHR technology in their first year of participation and demonstrate meaningful use for up to five remaining participation years. Medicaid EHR incentive payments to Providers are 100% federally funded; however, the Medicaid EHR incentive program is voluntarily offered by individual states. Although CMS established January 3, 2011 as the earliest date states could offer Medicaid EHR incentive payments if they so choose, states must develop and receive CMS approval of state plans prior to offering Medicaid incentive payments. As of September 30, 2011, CMS had approved Medicaid EHR plans in all but one state (Nebraska) in which we operate. During the nine months ended September 30, 2011, we acquired certified EHR technology for all of our acute care hospitals and certain of our employed physicians. As a result, we recognized approximately $50 million of non-patient revenues related to estimated Medicaid ARRA HIT incentives, most of which we expect to receive by December 31, 2011 pursuant to the ARRA HIT programs in the various states in which we operate that received CMS approval as of September 30, 2011. These revenues offset approximately $66 million of operating expenses we incurred in 2011 related to our overall HIT implementation program. Not all states that have CMS approval have become fully operational for providers to register for Medicaid EHR incentive payments. For those that have, we are currently collecting and submitting the information required to register our hospitals for the Medicaid incentive payments. The final Medicaid incentive payment amount to which a Provider is entitled is determined by several variables that are subject to validation by the state prior to such payment being issued, as well as post-payment audits.

Children’s Hospital Graduate Medical Education Payments

Legislative authority for payments to freestanding children’s hospitals for direct and indirect expenses attributable to medical residency programs under the federal Public Health Service Act expired on September 30, 2011. Legislation to reauthorize the program through FFY 2016 at the same level of funding was approved by the House of Representatives on September 20, 2011 and is currently awaiting action in the Senate. We receive approximately $8 million in payments annually from the Children’s Hospital Graduate Medical Education Program for resident training expenses at St. Christopher’s Hospital for Children. We cannot predict what action Congress may ultimately take with regard to reauthorization of the program.

The Budget Control Act

On August 2, 2011, the President signed the Budget Control Act of 2011 (“BCA”) into law. The intent of the BCA is to reduce federal spending by at least $1.2 trillion over FFYs 2013 through 2021. The savings will be achieved by:

•

Spending caps on certain discretionary spending, excluding payments to providers under Medicare and Medicaid;

•

The creation of a bipartisan and bicameral Joint Select Committee of Congress charged with developing a legislative proposal to reduce the federal deficit by at least an additional $1.5 trillion by FFY 2021; and

•

An automatic $1.2 trillion reduction (or enough to make up any shortfall between actual cuts enacted and $1.2 trillion), allocated 50% to defense and 50% to non-defense discretionary spending, divided equally amongst FFYs 2013 through 2021 and enforced by sequestration that will begin during the first quarter of CY 2013 if legislation cutting $1.5 trillion is not enacted by January 15, 2012.

The deadline for the Joint Select Committee to issue a proposal is November 23, 2011. We cannot predict the size or scope of reductions to government health programs that might be included in a committee proposal, but options under consideration by the committee reportedly include, but are not limited to: (1) reducing Medicare reimbursement for hospital bad debts associated with Medicare beneficiary copayments and deductibles; (2) reducing or eliminating some payments for graduate medical education; (3) placing limits on state provider tax programs, such as a cap on the tax rate; (4) developing a new blended rate for federal matching payments to states for Medicaid and other health programs; and (5) expanding the recoupment of supposed overpayments to hospitals relating to the conversion to inpatient MS-DRGs.

If the Joint Select Committee process fails to result in the enactment of legislation by January 15, 2012 that reduces the deficit by at least $1.5 trillion, and no additional legislation is enacted to amend the BCA sequestration mandate, sequestration of up to 2% of Medicare provider payments would begin during the first quarter of CY 2013. Federal Medicaid payments to states are excluded from sequestration, but budget pressures caused by cuts to other federal payments could cause some states to consider additional Medicaid reductions to balance their budgets.

PRIVATE INSURANCE

Managed Care

We currently have thousands of managed care contracts with various HMOs and PPOs. HMOs generally maintain a full-service health care delivery network comprised of physician, hospital, pharmacy and ancillary service providers that HMO members must access through an assigned “primary care” physician. The member’s care is then

managed by his or her primary care physician and other network providers in accordance with the HMO’s quality assurance and utilization review guidelines so that appropriate health care can be efficiently delivered in the most cost-effective manner. HMOs typically provide reduced benefits or reimbursement (or none at all) to their members who use non-contracted health care providers for non-emergency care.

PPOs generally offer limited benefits to members who use non-contracted health care providers. PPO members who use contracted health care providers receive a preferred benefit, typically in the form of lower co-payments, co-insurance or deductibles. As employers and employees have demanded more choice, managed care plans have developed hybrid products that combine elements of both HMO and PPO plans, including high-deductible health care plans that may have limited benefits, but cost the employee less in premiums.

The amount of our managed care net patient revenues during the nine months ended September 30, 2011 and 2010 was $3.9 billion and $3.7 billion, respectively. Approximately 62% of our managed care net patient revenues for the nine months ended September 30, 2011 was derived from our top ten managed care payers. National payers generate approximately 44% of our total net managed care revenues. The remainder comes from regional or local payers. At both September 30, 2011 and December 31, 2010, approximately 57% of our net accounts receivable related to continuing operations were due from managed care payers.

Revenues under managed care plans are based primarily on payment terms involving predetermined rates per diagnosis, per-diem rates, discounted fee-for-service rates and other similar contractual arrangements. These revenues are also subject to review and possible audit by the payers. The payers are billed for patient services on an individual patient basis. An individual patient’s bill is subject to adjustment on a patient-by-patient basis in the ordinary course of business by the payers following their review and adjudication of each particular bill. We estimate the discounts for contractual allowances at the individual hospital level utilizing billing data on an individual patient basis. At the end of each month, on an individual hospital basis, we estimate our expected reimbursement for patients of managed care plans based on the applicable contract terms. We believe it is reasonably likely for there to be an approximately 3% increase or decrease in the estimated contractual allowances related to managed care plans. Based on reserves as of September 30, 2011, a 3% increase or decrease in the estimated contractual allowance would impact the estimated reserves by approximately $8 million. Some of the factors that can contribute to changes in the contractual allowance estimates include: (1) changes in reimbursement levels for procedures, supplies and drugs when threshold levels are triggered; (2) changes in reimbursement levels when stop-loss or outlier limits are reached; (3) changes in the admission status of a patient due to physician orders subsequent to initial diagnosis or testing; (4) final coding of in-house and discharged-not-final-billed patients that change reimbursement levels; (5) secondary benefits determined after primary insurance payments; and (6) reclassification of patients among insurance plans with different coverage levels. Contractual allowance estimates are periodically reviewed for accuracy by taking into consideration known contract terms, as well as payment history. Although we do not separately accumulate and disclose the aggregate amount of adjustments to the estimated reimbursement for every patient bill, we believe our estimation and review process enables us to identify instances on a timely basis where such estimates need to be revised. We do not believe there were any adjustments to estimates of individual patient bills that were material to our revenues. In addition, on a corporate-wide basis, we do not record any general provision for adjustments to estimated contractual allowances for managed care plans.

We expect managed care governmental admissions to continue to increase as a percentage of total managed care admissions over the near term. However, the managed Medicare and Medicaid insurance plans typically generate lower yields than commercial managed care plans, which have been experiencing an improved pricing trend. Although we have had 25 consecutive quarters of improved year-over-year managed care pricing, we expect some moderation in the pricing percentage increases in future years. It is not clear what impact, if any, the increased obligations on managed care and other payers imposed by the Affordable Care Act will have on our ability to negotiate reimbursement increases. In the nine months ended September 30, 2011, our commercial managed care net inpatient revenue per admission from our acute care hospitals was approximately 80% higher than our aggregate yield on a per admission basis from government payers, including managed Medicare and Medicaid insurance plans.

Indemnity

An indemnity-based agreement generally requires the insurer to reimburse an insured patient for health care expenses after those expenses have been incurred by the patient, subject to policy conditions and exclusions. Unlike an HMO member, a patient with indemnity insurance is free to control his or her utilization of health care and selection of health care providers.

SELF-PAY PATIENTS

Self-pay patients are patients who do not qualify for government programs payments, such as Medicare and Medicaid, and who do not have some form of private insurance and, therefore, are responsible for their own medical bills. A significant portion of our self-pay patients is being admitted through our hospitals’ emergency departments and often requires high-acuity treatment that is more costly to provide and, therefore, results in higher billings, which are the least collectible of all accounts. We believe that our level of self-pay patients has been higher in the last several years than previous periods due to a combination of broad economic factors, including increased unemployment rates, reductions in state Medicaid budgets, increasing numbers of individuals and employers who choose not to purchase insurance, and an increased burden of co-payments and deductibles to be made by patients instead of insurers.

Self-pay accounts pose significant collectability problems. At both September 30, 2011 and December 31, 2010, approximately 7% of our net accounts receivable related to continuing operations were due from self-pay patients. Further, a significant portion of our provision for doubtful accounts relates to self-pay patients, as well as co-payments and deductibles owed to us by patients with insurance. Over the longer term, several initiatives we have previously announced should help address this challenge. For example, our Compact with Uninsured Patients (“Compact”) is designed to offer managed care-style discounts to certain uninsured patients, which enables us to offer lower rates to those patients who historically have been charged standard gross charges. A significant portion of those charges had previously been written down in our provision for doubtful accounts. Under the Compact, the discount offered to uninsured patients is recognized as a contractual allowance, which reduces net operating revenues at the time the self-pay accounts are recorded. The uninsured patient accounts, net of contractual allowances recorded, are further reduced to their net realizable value through provision for doubtful accounts based on historical collection trends for self-pay accounts and other factors that affect the estimation process.

The estimated costs (based on selected operating expenses, which include salaries, wages and benefits, supplies and other operating expenses) of caring for our self-pay patients for the three months ended September 30, 2011 and 2010 were approximately $105 million and $97 million, respectively, and for the nine months ended September 30, 2011 and 2010 were approximately $298 million and $285 million, respectively. We also provide charity care to patients who are financially unable to pay for the health care services they receive. Most patients who qualify for charity care are charged a per-diem amount for services received, subject to a cap. Except for the per-diem amounts, our policy is not to pursue collection of amounts determined to qualify as charity care; therefore, we do not report these amounts in net operating revenues or in provision for doubtful accounts. Most states include an estimate of the cost of charity care in the determination of a hospital’s eligibility for Medicaid DSH payments. The estimated costs (based on the selected operating expenses described above) of caring for charity care patients for the three months ended September 30, 2011 and 2010 were approximately $33 million and $36 million, respectively, and for the nine months ended September 30, 2011 and 2010 were approximately $96 million and $90 million, respectively. Our method of measuring the estimated costs uses adjusted self-pay/charity patient days multiplied by selected operating expenses per adjusted patient day. The adjusted self-pay/charity patient days represents actual self-pay/charity patient days adjusted to include self-pay/charity outpatient services by multiplying actual self-pay/charity patient days by the sum of gross self-pay/charity inpatient revenues and gross self-pay/charity outpatient revenues and dividing the results by gross self-pay/charity inpatient revenues.

The expansion of health insurance coverage under the Affordable Care Act may result in a material increase in the number of patients using our facilities who have either private or public program coverage. However, because of the many variables involved, we are unable to predict with certainty the net effect on us of the expected increase in revenues and expected decrease in bad debt expense from providing care to previously uninsured and underinsured individuals, and numerous other provisions in the law that may affect us. In addition, even after implementation of the Affordable Care Act, we may continue to experience a high level of bad debt expense and have to provide uninsured discounts and charity care for undocumented aliens who are not permitted to enroll in a health insurance exchange or government health care program.

RESULTS OF OPERATIONS

The following two tables summarize our net operating revenues, operating expenses and operating income from continuing operations, both in dollar amounts and as percentages of net operating revenues, for the three and nine months ended September 30, 2011 and 2010:


	Three Months Ended September 30,						Nine Months Ended September 30,
	2011			2010			2011			2010
Net operating revenues:
General hospitals	$	2,257		$	2,200		$	6,999		$	6,723
Other operations		85			62			223			181

Net operating revenues		2,342			2,262			7,222			6,904
Operating expenses:
Salaries, wages and benefits		1,019			977			3,053			2,933
Supplies		388			390			1,191			1,183
Provision for doubtful accounts		193			187			546			549
Other operating expenses, net		547			505			1,581			1,470
Depreciation and amortization		103			101			308			293
Impairment of long-lived assets and goodwill, and restructuring charges		8			3			18			1
Litigation and investigation costs		5			2			24			6

Operating income	$	79		$	97		$	501		$	469


	Three Months Ended September 30,						Nine Months Ended September 30,
	2011			2010			2011			2010
Net operating revenues:
General hospitals		96.4	%		97.3	%		96.9	%		97.4	%
Other operations		3.6	%		2.7	%		3.1	%		2.6	%

Net operating revenues		100.0	%		100.0	%		100.0	%		100.0	%
Operating expenses:
Salaries, wages and benefits		43.5	%		43.2	%		42.3	%		42.5	%
Supplies		16.6	%		17.2	%		16.5	%		17.1	%
Provision for doubtful accounts		8.2	%		8.3	%		7.6	%		8.0	%
Other operating expenses, net		23.4	%		22.3	%		21.9	%		21.3	%
Depreciation and amortization		4.4	%		4.5	%		4.3	%		4.2	%
Impairment of long-lived assets and goodwill, and restructuring charges		0.3	%		0.1	%		0.2	%		—	%
Litigation and investigation costs		0.2	%		0.1	%		0.3	%		0.1	%

Operating income		3.4	%		4.3	%		6.9	%		6.8	%

Net operating revenues of our continuing general hospitals include inpatient and outpatient revenues, as well as nonpatient revenues (primarily ARRA HIT Medicaid incentives as discussed above, rental income, management fee revenue and income from services such as cafeterias, gift shops and parking) and other miscellaneous revenue. Net operating revenues of other operations primarily consist of revenues from (1) physician practices, (2) a long-term acute care hospital and (3) revenue cycle services provided by our Conifer subsidiary. None of our individual hospitals represented more than 5% of our net operating revenues for the nine months ended September 30, 2011, and only one of our individual hospitals represented more than 5% (approximately 5.9%) of our total assets, excluding goodwill and intercompany receivables, at September 30, 2011.

Net operating revenues from our other operations were $223 million and $181 million in the nine months ended September 30, 2011 and 2010, respectively. The increase in net operating revenues from other operations during 2011 primarily relates to our additional owned physician practices and revenue cycle services provided by our Conifer subsidiary.

The tables below show certain selected historical operating statistics of our continuing hospitals:


	Three Months Ended September 30,									Nine Months Ended September 30,
Admissions, Patient Days and Surgeries	2011			2010			Increase (Decrease)			2011			2010			Increase (Decrease)
Total admissions		127,520			125,645			1.5	%		388,372			385,995			0.6	%
Paying admissions (excludes charity and uninsured)		118,505			116,672			1.6	%		362,364			360,156			0.6	%
Charity and uninsured admissions		9,015			8,973			0.5	%		26,008			25,839			0.7	%
Admissions through emergency department		75,624			72,914			3.7	%		233,211			226,004			3.2	%
Paying admissions as a percentage of total admissions		92.9	%		92.9	%		—	(1)		93.3	%		93.3	%		—	(1)
Charity and uninsured admissions as a percentage of total admissions		7.1	%		7.1	%		—	(1)		6.7	%		6.7	%		—	(1)
Emergency department admissions as a percentage of total admissions		59.3	%		58.0	%		1.3	(1)		60.0	%		58.6	%		1.4	(1)
Surgeries – inpatient		37,721			37,916			(0.5	)%		111,441			113,114			(1.5	)%
Surgeries – outpatient		56,222			53,148			5.8	%		163,506			157,233			4.0	%
Total surgeries		93,943			91,064			3.2	%		274,947			270,347			1.7	%
Patient days – total		601,915			596,810			0.9	%		1,852,297			1,864,127			(0.6	)%
Adjusted patient days(2)		925,165			913,049			1.3	%		2,814,532			2,800,483			0.5	%
Average length of stay (days)		4.7			4.7			—	(1)		4.8			4.8			—	(1)
Adjusted patient admissions(2)		198,110			193,670			2.3	%		595,325			584,407			1.9	%
Number of acute hospitals (at end of period)		49			49			—	(1)		49			49			—	(1)
Licensed beds (at end of period)		13,453			13,430			0.2	%		13,453			13,430			0.2	%
Average licensed beds		13,440			13,423			0.1	%		13,447			13,430			0.1	%
Utilization of licensed beds(3)		48.7	%		48.3	%		0.4	(1)		50.5	%		50.8	%		(0.3	)(1)

(1)	The change is the difference between the 2011 and 2010 amounts shown.

(2)	Adjusted patient days/admissions represents actual patient days/admissions adjusted to include outpatient services by multiplying actual patient days/admissions by the sum of gross inpatient revenues and outpatient revenues and dividing the results by gross inpatient revenues.

(3)	Utilization of licensed beds represents patient days divided by number of days in the period divided by average licensed beds.


	Three Months Ended September 30,									Nine Months Ended September 30,
Outpatient Visits	2011			2010			Increase (Decrease)			2011			2010			Increase (Decrease)
Total visits		1,009,936			976,310			3.4	%		3,036,614			2,917,931			4.1	%
Paying visits (excludes charity and uninsured)		901,695			871,930			3.4	%		2,723,944			2,612,180			4.3	%
Charity and uninsured visits		108,241			104,380			3.7	%		312,670			305,751			2.3	%
Emergency department visits		373,295			359,658			3.8	%		1,116,342			1,072,088			4.1	%
Surgery visits		56,222			53,148			5.8	%		163,506			157,233			4.0	%
Paying visits as a percentage of total visits		89.3	%		89.3	%		—	(1)		89.7	%		89.5	%		0.2	(1)
Charity visits and uninsured visits as a percentage of total visits		10.7	%		10.7	%		—	(1)		10.3	%		10.5	%		(0.2	)(1)

(1)	The change is the difference between 2011 and 2010 amounts shown.


	Three Months Ended September 30,							Nine Months Ended September 30,
Revenues	2011		2010		Increase (Decrease)			2011		2010		Increase (Decrease)
Net operating revenues	$	2,342	$	2,262		3.5	%	$	7,222	$	6,904		4.6	%
Revenues from the uninsured	$	161	$	163		(1.2	)%	$	460	$	487		(5.5	)%
Net inpatient revenues(1)	$	1,477	$	1,430		3.3	%	$	4,627	$	4,452		3.9	%
Net outpatient revenues(1)	$	749	$	734		2.0	%	$	2,233	$	2,173		2.8	%

(1)

Net inpatient revenues and net outpatient revenues are components of net operating revenues. Net inpatient revenues include self-pay revenues of $69 million and $63 million for the three months ended September 30, 2011 and 2010, respectively, and $203 million and $195 million for the nine months ended September 30, 2011 and 2010, respectively. Net outpatient revenues include self-pay revenues of $92 million and $100 million for the three months ended September 30, 2011 and 2010, respectively, and $257 million and $292 million for the nine months ended September 30, 2011 and 2010, respectively.


	Three Months Ended September 30,							Nine Months Ended September 30,
Revenues on a Per Admission, Per Patient Day and Per Visit Basis	2011		2010		Increase (Decrease)			2011		2010		Increase (Decrease)
Net inpatient revenue per admission	$	11,582	$	11,381		1.8	%	$	11,914	$	11,534		3.3	%
Net inpatient revenue per patient day	$	2,454	$	2,396		2.4	%	$	2,498	$	2,388		4.6	%
Net outpatient revenue per visit	$	742	$	752		(1.3	)%	$	735	$	745		(1.3	)%
Net patient revenue per adjusted patient admission(1)	$	11,236	$	11,174		0.6	%	$	11,523	$	11,336		1.6	%
Net patient revenue per adjusted patient day(1)	$	2,406	$	2,370		1.5	%	$	2,437	$	2,366		3.0	%

(1)	Adjusted patient days/admissions represents actual patient days/admissions adjusted to include outpatient services by multiplying actual patient days/admissions by the sum of gross inpatient revenues and outpatient revenues and dividing the results by gross inpatient revenues.


	Three Months Ended September 30,							Nine Months Ended September 30,
Selected Operating Expenses	2011		2010		Increase (Decrease)			2011		2010		Increase (Decrease)
Salaries, wages and benefits	$	1,019	$	977		4.3	%	$	3,053	$	2,933		4.1	%
Supplies		388		390		(0.5	)%		1,191		1,183		0.7	%
Other operating expenses		547		505		8.3	%		1,581		1,470		7.6	%

Total	$	1,954	$	1,872		4.4	%	$	5,825	$	5,586		4.3	%
Rent/lease expense(1)	$	37	$	35		5.7	%	$	107	$	101		5.9	%
Salaries, wages and benefits per adjusted patient day(2)	$	1,102	$	1,070		3.0	%	$	1,085	$	1,047		3.6	%
Supplies per adjusted patient day(2)		419		427		(1.9	)%		423		422		0.2	%
Other operating expenses per adjusted patient day(2)		591		553		6.9	%		562		526		6.8	%

Total per adjusted patient day	$	2,112	$	2,050		3.0	%	$	2,070	$	1,995		3.8	%

(1)	Included in other operating expenses.

(2)	Adjusted patient days represent actual patient days adjusted to include outpatient services by multiplying actual patient days by the sum of gross inpatient revenues and outpatient revenues and dividing the results by gross inpatient revenues.


	Three Months Ended September 30,									Nine Months Ended September 30,
Provision for Doubtful Accounts	2011			2010			Increase (Decrease)			2011			2010			Increase (Decrease)
Provision for doubtful accounts	$	193		$	187			3.2	%	$	546		$	549			(0.5	)%
Provision for doubtful accounts as a percentage of net operating revenues		8.2	%		8.3	%		(0.1	)(1)		7.6	%		8.0	%		(0.4	)(1)
Collection rate on self-pay accounts(2)		27.7	%		29.1	%		(1.4	)(1)		27.7	%		29.1	%		(1.4	)(1)
Collection rate on commercial managed care accounts payers		98.4	%		98.3	%		0.1	(1)		98.4	%		98.3	%		0.1	(1)

(1)	The change is the difference between the 2011 and 2010 amounts shown.

(2)	Self-pay accounts receivable are comprised of both uninsured and balance-after insurance receivables.

THREE MONTHS ENDED SEPTEMBER 30, 2011 COMPARED TO THREE MONTHS ENDED SEPTEMBER 30, 2010

Revenues

During the three months ended September 30, 2011, net operating revenues from continuing operations increased 3.5%, which included a 2.9% increase in net patient revenues, compared to the three months ended September 30, 2010.

Our net inpatient revenues for the three months ended September 30, 2011 increased by 3.3% compared to the three months ended September 30, 2010. Several factors impacted our net inpatient revenues in the three months ended September 30, 2011 compared to the three months ended September 30, 2010, including:

•

Improved managed care pricing as a result of renegotiated contracts;

•

Increased Medicaid-related admissions, the reimbursement for which is lower than other payers;

•

The recognition by our Philadelphia hospitals of $6 million of revenues that were approved for distribution to us in the three months ended September 30, 2011 by a Philadelphia HMO in which we hold a minority interest;

•

Medicaid DSH payments and other state-funded subsidy revenues of $41 million in the three months ended September 30, 2011 compared to $37 million in the three months ended September 30, 2010 (this change is primarily attributable to (i) a $7 million increase in the three months ended September 30, 2011 primarily due to the Pennsylvania provider fee program, and (ii) a $4 million reduction in the three months ended September 30, 2011 due to a new regulation issued by the State of Missouri); and

•

Unfavorable adjustments for prior-year cost reports and related valuation allowances of approximately $2 million in the three months ended September 30, 2011 compared to favorable adjustments of $2 in the three months ended September 30, 2010.

Patient days increased by 0.9% and total admissions increased by 1.5% during the three months ended September 30, 2011 compared to the three months ended September 30, 2010. We believe the following factors contributed to the constrained growth in our inpatient volume levels: (1) the current weak economic conditions, which we believe have adversely impacted the level of elective procedures performed at our hospitals; (2) loss of patients to competing health care providers; (3) industry trends reflecting the shift of certain clinical procedures being performed in an outpatient setting rather than in an inpatient setting; and (4) strategic reduction of services related to our Targeted Growth Initiative, which seeks to de-emphasize or eliminate less profitable service lines.

Net outpatient revenues and total outpatient visits increased 2.0% and 3.4%, respectively, during the three months ended September 30, 2011 compared to the three months ended September 30, 2010. The growth in our outpatient revenues and volumes was substantially related to the acquisition of various outpatient centers during 2010 and 2011. Outpatient revenue per visit declined 1.3% primarily due to the provision of lower acuity services by outpatient centers we acquired in 2010 and 2011, as well as an unfavorable shift in our total outpatient payer mix, including a decline in commercial managed care outpatient visits as a percentage of total outpatient visits in the three months ended September 30, 2011 as compared to the same period in 2010.

Net operating revenues in the three months ended September 30, 2011 included $20 million of non-patient revenue related to the revenue cycle services provided by our Conifer subsidiary compared to $8 million in the three months ended September 30, 2010.

Salaries, Wages and Benefits

Salaries, wages and benefits expense as a percentage of net operating revenues was 43.5% for the three months ended September 30, 2011 compared to 43.2% for the three months ended September 30, 2010. Salaries, wages and benefits per adjusted patient day increased 3.0% in the three months ended September 30, 2011 as compared to the same period in 2010. This increase is primarily due to annual merit increases for our employees, as well as an increase in the number of physicians we employ, increased overtime costs and increased employee-related costs associated with our HIT implementation program,

partially offset by reductions in workers’ compensation expense and annual incentive compensation expense, in the three months ended September 30, 2011 as compared to the three months ended September 30, 2010. Included in salaries, wages and benefits expense is $3 million of expense due to a 107 basis point decrease in the interest rate used to estimate the discounted present value of projected future workers’ compensation liabilities. Salaries, wages and benefits expense also included stock-based compensation expense of $5 million in each of the three month periods ended September 30, 2011 and 2010.

As of September 30, 2011, approximately 21% of our employees were represented by various labor unions. To date, labor unions represent registered nurses, service and maintenance workers, and other employees at 18 of our general hospitals, the majority of which are in California. We are in the process of renegotiating the collective bargaining agreements for all of the facilities whose contracts have expired and negotiating new contracts where employees have chosen union representation in 2011. At this time, we are unable to predict the outcome of the negotiations, but increases in salaries, wages and benefits could result from these agreements. Furthermore, there is a possibility that strikes could occur during the negotiation process, which could increase our labor costs and have an adverse effect on our patient admissions and net operating revenues. In addition, under the current terms of our peace accords with two labor unions, three of our general hospitals may be subject to union organizing activities during the remainder of 2011 and two of our hospitals are currently facing active campaigns.

Supplies

Supplies expense as a percentage of net operating revenues was 16.6% for the three months ended September 30, 2011 compared to 17.2% for the three months ended September 30, 2010. Supplies expense per adjusted patient day decreased 1.9% in the three months ended September 30, 2011 compared to the same period in 2010. Supplies expense was favorably impacted by a decline in orthopedic and cardiology-related costs due to renegotiated prices and lower volume levels, partially offset by increased costs of surgical supplies. In general, supplies expense changes are primarily attributable to changes in our patient volume levels and the mix of procedures performed.

We strive to control supplies expense through product standardization, contract compliance, improved utilization, bulk purchases and operational improvements. The items of current cost reduction focus continue to be cardiac stents and pacemakers, orthopedics and implants, and high-cost pharmaceuticals. We also utilize the group-purchasing strategies and supplies-management services of MedAssets, Inc., a company that offers group-purchasing procurement strategy, outsourcing and e-commerce services to the health care industry.

Provision for Doubtful Accounts

The provision for doubtful accounts as a percentage of net operating revenues was 8.2% for the three months ended September 30, 2011 compared to 8.3% for the three months ended September 30, 2010. Key factors contributing to the change in the provision for doubtful accounts for the three months ended September 30, 2011 compared to the same period in 2010 include (i) a $2 million decrease in revenues from the uninsured in the 2011 period compared to the same period in 2010, (ii) the $9 million favorable adjustment in the 2010 period for Medicare bad debts to be claimed on our cost reports compared to $2 million in the 2011 period, and (iii) a 140 basis point decline in our collection rate on self-pay accounts compared to the 2010 period. Our self-pay collection rate, which is the blended collection rate for uninsured and balance-after insurance accounts receivable, declined to approximately 27.7% as of September 30, 2011 from 29.1% as of September 30, 2010.

The table below shows the net accounts receivable and allowance for doubtful accounts by payer at September 30, 2011 and December 31, 2010:


	September 30, 2011								December 31, 2010
	Accounts Receivable Before Allowance for Doubtful Accounts			Allowance for Doubtful Accounts		Net			Accounts Receivable Before Allowance for Doubtful Accounts			Allowance for Doubtful Accounts		Net
Medicare	$	165		$	—	$	165		$	159		$	—	$	159
Medicaid		125			—		125			118			—		118
Net cost report settlements payable and valuation allowances		(62	)		—		(62	)		(26	)		—		(26	)
Managed care		761			69		692			714			60		654
Self-pay uninsured		198			175		23			194			172		22
Self-pay balance after insurance		138			80		58			119			66		53
Estimated future recoveries from accounts assigned to collection agency subsidiary		56			—		56			33			—		33
Other payers		213			46		167			168			39		129

Total continuing operations		1,594			370		1,224			1,479			337		1,142
Total discontinued operations		4			7		(3	)		16			15		1

	$	1,598		$	377	$	1,221		$	1,495		$	352	$	1,143

We provide revenue cycle management and patient communications services through our Conifer subsidiary, which has performed systematic analyses to focus attention on the drivers of bad debt for each of our hospitals. While emergency department use is the primary contributor to our provision for doubtful accounts in the aggregate, this is not the case at all hospitals. As a result, we have increased our focus on targeted initiatives that concentrate on non-emergency department patients as well. These initiatives are intended to promote process efficiencies in working self-pay accounts, as well as co-payment and deductible amounts owed to us by patients with insurance, that we deem highly collectible. We are dedicated to modifying and refining our processes as needed, enhancing our technology and improving staff training throughout the revenue cycle in an effort to increase collections and reduce accounts receivable.

A significant portion of our provision for doubtful accounts relates to self-pay patients, as well as co-payments and deductibles owed to us by patients with insurance. Collection of accounts receivable has been a key area of focus, particularly over the past several years, as we have experienced adverse changes in our business mix. At September 30, 2011, our collection rate on self-pay accounts was approximately 27.7%, including collections from point-of-service through collections by our collection agency subsidiary. We have experienced a downward trend in our self-pay collection rate as follows: 29.9% at March 31, 2010; 29.5% at June 30, 2010; 29.1% at September 30, 2010; 28.3% at December 31, 2010; 27.9% at March 31, 2011; and 27.9% at June 30, 2011. These self-pay collection rates include payments made by patients, including co-payments and deductibles paid by patients with insurance, prior to an account being classified and assigned to our collection agency subsidiary. Based on our accounts receivable from self-pay patients and co-payments and deductibles owed to us by patients with insurance at September 30, 2011, a hypothetical 10% decline in our self-pay collection rate, or approximately 3%, would result in an unfavorable adjustment to provision for doubtful accounts of approximately $8 million.

Payment pressure from managed care payers also affects our provision for doubtful accounts. We typically experience ongoing managed care payment delays and disputes; however, we continue to work with these payers to obtain adequate and timely reimbursement for our services. Our estimated collection rate from managed care payers was approximately 98.4% at September 30, 2011 and December 31, 2010, which includes collections from point-of-service through collections by our collection agency subsidiary. We experienced a temporary slowdown in collections related to commercial and governmental managed care accounts receivable in the nine months ended September 30, 2011 as a result of a revenue cycle operational realignment we initiated that resulted in the closure of two of our service centers, which we anticipate will create long-term operating efficiencies.

We continue to focus on revenue cycle initiatives to improve cash flow. In 2011, we completed the transition of the patient access staff and operations of the majority of our hospitals to Conifer. This initiative is focused on standardizing and improving patient access processes, including pre-registration, registration, verification of eligibility and benefits, liability

identification and collection, and financial counseling, while more clearly aligning responsibility for revenue cycle activities with Conifer. The goals of the effort are focused on reducing denials, improving service levels to patients and increasing the quality of accounts that end up in accounts receivable. Although we continue to focus on improving our methodology for evaluating the collectability of our accounts receivable, we may incur future charges if there are unfavorable changes in the trends affecting the net realizable value of our accounts receivable.

We manage our provision for doubtful accounts using hospital-specific goals and benchmarks such as (1) total cash collections, (2) point-of-service cash collections, (3) accounts receivable days outstanding (“AR Days”), and (4) accounts receivable by aging category. The following tables present the approximate aging by payer of our net accounts receivable from continuing operations of $1.287 billion and $1.168 billion at September 30, 2011 and December 31, 2010, respectively, excluding cost report settlements payable and valuation allowances of $63 million and $26 million at September 30, 2011 and December 31, 2010, respectively:


	September 30, 2011
	Medicare			Medicaid			Managed Care			Indemnity, Self-Pay and Other			Total
0-60 days		92	%		62	%		75	%		34	%		68	%
61-120 days		5	%		24	%		13	%		18	%		14	%
121-180 days		2	%		13	%		6	%		10	%		7	%
Over 180 days		1	%		1	%		6	%		38	%		11	%

Total		100	%		100	%		100	%		100	%		100	%


	December 31, 2010
	Medicare			Medicaid			Managed Care			Indemnity, Self-Pay and Other			Total
0-60 days		96	%		70	%		79	%		40	%		74	%
61-120 days		3	%		22	%		12	%		20	%		13	%
121-180 days		1	%		8	%		4	%		10	%		5	%
Over 180 days		—	%		—	%		5	%		30	%		8	%

Total		100	%		100	%		100	%		100	%		100	%

Our AR Days from continuing operations were 48 days at September 30, 2011 and 46 days at December 31, 2010, within our target of less than 50 days. AR Days are calculated as our accounts receivable from continuing operations on the last date in the quarter divided by our revenues from continuing operations for the quarter ended on that date divided by the number of days in the quarter.

As of September 30, 2011, we had a cumulative total of patient account assignments dating back at least three years or older of approximately $3.8 billion related to our continuing operations being pursued by our collection agency subsidiary. These accounts have already been written off and are not included in our receivables or in the allowance for doubtful accounts; however, an estimate of future recoveries from all the accounts assigned to our collection agency subsidiary is determined based on our historical experience and recorded in accounts receivable.

Patient advocates from our Medical Eligibility Program (“MEP”) screen patients in the hospital to determine whether those patients meet eligibility requirements for financial assistance programs. They also expedite the process of applying for these government programs. Receivables from patients who are potentially eligible for Medicaid are classified as Medicaid pending, under our MEP, with appropriate contractual allowances recorded. Based on recent trends, approximately 89% of all accounts in our MEP are ultimately approved for benefits under a government program such as Medicaid.

The following table shows the approximate amount of net accounts receivable in our MEP, still awaiting determination of eligibility under a government program at September 30, 2011 and December 31, 2010, by aging category:


	September 30,		December 31,
	2011		2010
0-60 days	$	89	$	100
61-120 days		18		21
121-180 days		6		8
Over 180 days(1)		—		—

Total	$	113	$	129

(1)	Includes accounts receivable of $16 million at September 30, 2011 and $13 million at December 31, 2010 that are fully reserved.

Other Operating Expenses, Net

Other operating expenses as a percentage of net operating revenues was 23.4% in the three months ended September 30, 2011 compared to 22.3% in the three months ended September 30, 2010. Other operating expenses per adjusted patient day increased by 6.9% in the three months ended September 30, 2011 as compared to the same period in 2010. This change is primarily due to increased physician and medical fees ($8 million), higher malpractice expense ($6 million, which includes $13 million of expense due to a 107 basis point decrease in the interest rate used to estimate the discounted present value of projected future malpractice liabilities, partially offset by improved claims experience trends), increased costs of contracted services ($9 million), increased systems implementation costs and information technology service contract expenses primarily related to our HIT implementation program ($2 million), increased physician relocation and income guarantee costs ($3 million), and increased repairs and maintenance expense ($5 million), partially offset by a $5 million gain on the sale of the building at the former campus of one of our hospitals.

Impairment of Long-Lived Assets and Goodwill and Restructuring Charges

During the three months ended September 30, 2011, we recorded net impairment and restructuring charges of $8 million, including a $4 million impairment charge for the write-down of buildings and equipment of one of our previously impaired hospitals to their estimated fair values, primarily due to a decline in the fair value of real estate in the market in which the hospital operates and a decline in the estimated fair value of equipment. Material adverse trends in our most recent estimates of future undiscounted cash flows of the hospital, consistent with our previous estimates in prior years when impairment charges were recorded at this hospital, indicated the carrying value of the hospital’s long-lived assets was not recoverable from the estimated future cash flows. We believe the most significant factors contributing to the continuing adverse financial trends include reductions in volumes of insured patients, shifts in payer mix from commercial to governmental payers combined with reductions in reimbursement rates from governmental payers, and high levels of uninsured patients. As a result, we updated the estimate of the fair value of the hospital’s long-lived assets and compared the fair value estimate to the carrying value of the hospital’s long-lived assets. Because the fair value estimate was lower than the carrying value of the hospital’s long-lived assets, an impairment charge was recorded for the difference in the amounts. Unless the anticipated future financial trends of this hospital improve to the extent that the estimated future undiscounted cash flows exceed the carrying value of the long-lived assets, this hospital is at risk of future impairments, particularly if we spend significant amounts of capital at the hospital without generating a corresponding increase in the hospital’s fair value or if the fair value of the hospital’s real estate or equipment continues to decline. The aggregate carrying value of assets held and used of the hospital for which an impairment charge was recorded was $20 million as of September 30, 2011. In addition, we recorded $4 million of employee severance and other related costs during the three months ended September 30, 2011.

During the three months ended September 30, 2010, we recorded $3 million of impairment charges for the write-down of buildings, equipment and other long-lived assets, primarily capitalized software costs classified in other intangible assets, of one of our previously impaired hospitals as described above to their estimated fair values primarily due to a decline in the fair value of real estate in the market in which the hospital operates and a decline in the estimated fair value of equipment.

Our impairment tests presume stable, improving or, in some cases, declining results in our hospitals, which are based on programs and initiatives being implemented that are designed to achieve the hospital’s most recent projections. If these projections are not met, or if in the future negative trends occur that impact our future outlook, further impairments of long-lived assets and goodwill may occur, and we may incur additional restructuring charges.

Litigation and Investigation Costs

Litigation and investigation costs in continuing operations for the three months ended September 30, 2011 were $5 million compared to $2 million for the three months ended September 30, 2010. The 2011 amount is comprised of costs associated with the unsolicited acquisition proposal we received in November 2010, an accrual for a physician privileges case where an unfavorable jury verdict (subject to appeal) was rendered against us, and costs to defend the Company in various matters described in Note 11 to the Condensed Consolidated Financial Statements. The 2010 costs primarily relate to changes in reserve estimates established in connection with certain governmental reviews and costs to defend the Company in various matters.

Interest Expense

Interest expense for the three months ended September 30, 2011 was $59 million compared to $107 million for the three months ended September 30, 2010. The decrease in interest expense primarily relates to our repurchases of outstanding senior notes during 2010 and the $41 million favorable impact from the interest rate swap agreement we terminated in August 2011. See Note 5 to the Condensed Consolidated Financial Statements for additional information about this agreement.

Loss from Early Extinguishment of Debt

During the three months ended September 30, 2010, we recorded a loss from early extinguishment of debt of approximately $55 million, primarily related to the difference between the purchase prices and the par values of the $782 million aggregate principal amount of 7³/₈% senior notes due 2013 that we purchased during the period, as well as the write-off of unamortized note discounts, issuance costs and unrecognized interest rate hedge settlements associated with the notes.

Income Tax Benefit (Expense)

During the three months ended September 30, 2011, we recorded income tax expense of $4 million compared to a benefit of $1 billion during the three months ended September 30, 2010. The $1 billion income tax benefit in the 2010 period was primarily due to the elimination of substantially all of our valuation allowance for deferred tax assets during the three months ended September 30, 2010. We now recognize income tax expense that includes little or no change in the deferred tax valuation allowance, whereas in the 2010 period the tax impact associated with our earnings was substantially offset by the change in the deferred tax valuation allowance. See Note 12 to the Condensed Consolidated Financial Statements for additional detail about these amounts.

NINE MONTHS ENDED SEPTEMBER 30, 2011 COMPARED TO NINE MONTHS ENDED SEPTEMBER 30, 2010

Revenues

During the nine months ended September 30, 2011, net operating revenues from continuing operations increased 4.6%, which included a 3.5% increase in net patient revenues, compared to the nine months ended September 30, 2010.

Our net inpatient revenues for the nine months ended September 30, 2011 increased by 3.9% compared to the nine months ended September 30, 2010. Several factors impacted our net inpatient revenues in the nine months ended September 30, 2011 compared to the nine months ended September 30, 2010, including:

•

Medicaid DSH payments and other state-funded subsidy revenues of $199 million in the nine months ended September 30, 2011 compared to $134 million in the nine months ended September 30, 2010 (significant changes in DSH revenue include: (i) $63 million of additional revenues, net of provider fees and other expenses, related to the California hospital fee program, which was recorded in the nine months ended September 30, 2011 because CMS issued the final required federal approval of the program on January 18, 2011; (ii) a $31 million increase in the nine months ended September 30, 2011 related to our Pennsylvania hospitals, primarily due to the Pennsylvania provider fee program that was approved by CMS in the 2011 period; and (iii) an $18 million reduction in the nine months ended September 30, 2011 primarily due to a new regulation issued by the State of Missouri);

•

Improved managed care pricing as a result of renegotiated contracts;

•

Increased Medicaid-related admissions, the reimbursement for which is lower than other payers;

•

A $2 million unfavorable patient revenue adjustment in the nine months ended September 30, 2011 related to the portion of our bad debts that will not be reimbursed by Medicare compared to $11 million in the nine months ended September 30, 2010;

•

An unfavorable patient revenue adjustment of approximately $20 million in the nine months ended September 30, 2010 for the estimated impact on our DSH payments as a result of estimated lower Supplemental Security Income (“SSI”) percentages at certain of our hospitals;

•

Favorable adjustments of $4 million in the nine months ended September 30, 2010 for prior-year cost reports and related valuation allowances compared to less than $1 million in the 2011 period; and

•

The recognition by our Philadelphia hospitals of $6 million of revenues that were approved for distribution to us in the nine months ended September 30, 2011 by a Philadelphia HMO in which we hold a minority interest.

Patient days decreased by 0.6%, while total admissions increased by 0.6%, during the nine months ended September 30, 2011 compared to the nine months ended September 30, 2010. We believe the following factors contributed to the changes in our inpatient volume levels: (1) the current weak economic conditions, which we believe have adversely impacted the level of elective procedures performed at our hospitals; (2) loss of patients to competing health care providers; (3) industry trends reflecting the shift of certain clinical procedures being performed in an outpatient setting rather than in an inpatient setting; and (4) strategic reduction of services related to our Targeted Growth Initiative, which seeks to de-emphasize or eliminate less profitable service lines.

Net outpatient revenues and total outpatient visits increased 2.8% and 4.1%, respectively, during the nine months ended September 30, 2011 compared to the nine months ended September 30, 2010. The growth in our outpatient revenues and volumes was substantially related to the acquisition of various outpatient centers during 2010 and 2011. Outpatient revenue per visit declined 1.3% primarily due to the provision of lower acuity services by outpatient centers we acquired in 2010 and 2011, as well as an unfavorable shift in our total outpatient payer mix, including a decline in managed care outpatient visits as a percentage of total outpatient visits in the nine months ended September 30, 2011 as compared to the same period in 2010.

Net operating revenues in the nine months ended September 30, 2011 included $50 million of non-patient revenue related to estimated state Medicaid ARRA HIT incentives and $44 million related to the revenue cycle services provided by our Conifer subsidiary. In the nine months ended September 30, 2010, we recorded non-patient revenue of $23 million related to the revenue cycle services provided by our Conifer subsidiary.

Salaries, Wages and Benefits

Salaries, wages and benefits expense as a percentage of net operating revenues decreased 0.2% for the nine months ended September 30, 2011 compared to the nine months ended September 30, 2010. Salaries, wages and benefits per adjusted patient day increased 3.6% in the nine months ended September 30, 2011 as compared to the same period in 2010. This increase is primarily due to annual merit increases for our employees, as well as an increase in the number of physicians we employ, increased overtime costs, increased health benefits costs, increased 401(k) plan expense and increased employee-related costs associated with our HIT implementation program, partially offset by reductions in workers’ compensation expense and annual incentive compensation expense. Included in salaries, wages and benefits expense is $4 million of expense due to a 128 basis point decrease in the interest rate used to estimate the discounted present value of projected future workers’ compensation liabilities. Salaries, wages and benefits expense for the nine months ended September 30, 2011 and 2010 also included stock-based compensation expense of $17 million and $18 million, respectively.

Supplies

Supplies expense as a percentage of net operating revenues was 16.5% for the nine months ended September 30, 2011 compared to 17.1% for the nine months ended September 30, 2010. Supplies expense per adjusted patient day increased by 0.2% in the nine months ended September 30, 2011 compared to the same period in 2010. Supplies expense was unfavorably impacted by the higher cost of pharmaceuticals and increased costs of surgical supplies, partially offset by decreases in cardiology-related costs due to renegotiated prices and lower volume levels. The supplies expense changes are primarily attributable to changes in our patient volume levels in the 2011 period compared to the 2010 period.

Provision for Doubtful Accounts

The provision for doubtful accounts as a percentage of net operating revenues was 7.6% for the nine months ended September 30, 2011 compared to 8.0% for the nine months ended September 30, 2010. Key factors contributing to the change in the provision for doubtful accounts for the nine months ended September 30, 2011 compared to the same period in 2010 include (i) a $27 million decrease in revenues from the uninsured in the 2011 period compared to the same period in 2010, (ii) an $8 million favorable adjustment in the 2011 period for Medicare bad debts to be claimed on our cost reports compared to $37 million in the 2010 period, and (iii) lower collection rates on self-pay accounts in the 2011 period compared to the 2010 period. Our self-pay collection rate, which is the blended collection rate for uninsured and balance-after insurance accounts receivable, declined to approximately 27.7% as of September 30, 2011 from 29.1% as of September 30, 2010.

Other Operating Expenses, Net

Other operating expenses as a percentage of net operating revenues was 21.9% in the nine months ended September 30, 2011 compared to 21.3% in the nine months ended September 30, 2010. Other operating expenses per adjusted patient day increased by 6.8% in the nine months ended September 30, 2011 as compared to the same period in 2010. This change is due in part to a $29 million increase in malpractice expense in the nine months ended September 30, 2011 compared to the nine months ended September 30, 2010. The increase in malpractice expense is primarily attributable to several large unfavorable case reserve adjustments in the 2011 period as compared to the prior-year period, as well as the $16 million unfavorable impact of a 128 basis point decrease in the interest rate used to estimate the discounted present value of projected future malpractice liabilities in the nine months ended September 30, 2011. There were also increases in physician and medical fees ($21 million), increased costs of contracted services ($27 million), increased systems implementation costs and information technology service contract expenses primarily related to our HIT implementation program ($11 million), increased physician relocation and income guarantee costs ($9 million), increased hospital provider fees assessed by certain states in which we operate ($4 million, which were substantially offset by additional DSH payments recognized in net patient revenues), and increased repairs and maintenance expense ($14 million). These increases were partially offset by $7 million of lower consulting costs, gains of $8 million from the sale of the building at the former campus of one of our hospitals and a medical office building, and a favorable adjustment of $6 million relating to the estimated recovery of the employer portion of certain payroll taxes paid prior to April 2005 on behalf of medical residents, which was recorded in the nine months ended September 30, 2011.

Impairment of Long-Lived Assets and Goodwill and Restructuring Charges

During the nine months ended September 30, 2011, we recorded net impairment and restructuring charges of $18 million, including a $4 million impairment charge for the write-down of buildings and equipment of one of our previously impaired hospitals to their estimated fair values, primarily due to a decline in the fair value of real estate in the market in which the hospital operates and a decline in the estimated fair value of equipment. We also recorded an impairment charge of $1 million related to a cost basis investment, $7 million of employee severance costs, $3 million of lease termination costs and $3 million of other related costs.

During the nine months ended September 30, 2010, we recorded $1 million of net impairment and restructuring charges. We recorded $3 million for the write-down of buildings, equipment and other long-lived assets, primarily capitalized software costs classified in other intangible assets, of one of our previously impaired hospitals as described above to their estimated fair values primarily due to a decline in the fair value of real estate in the market in which the hospital operates and a decline in the estimated fair value of equipment. This charge was partially offset by a $2 million credit related to the collection of a note receivable due from a buyer of one of our previously divested hospitals, which had been fully reserved in a prior year.

Litigation and Investigation Costs

Litigation and investigation costs in continuing operations for the nine months ended September 30, 2011 were $24 million compared to $6 million for the nine months ended September 30, 2010. The 2011 amount is comprised of costs associated with the unsolicited acquisition proposal we received in November 2010, a settlement with the California Nurses Association, an accrual for a physician privileges case where an unfavorable jury verdict (subject to appeal) was rendered against us, and costs to defend the Company in various matters described in Note 11 to the Condensed Consolidated Financial Statements. The 2010 costs primarily relate to changes in reserve estimates established in connection with certain governmental reviews and costs to defend the Company in various matters.

Interest Expense

Interest expense for the nine months ended September 30, 2011 was $275 million compared to $323 million for the nine months ended September 30, 2010. The decrease in interest expense primarily relates to our repurchases of outstanding senior notes during 2010 and the $30 million favorable impact from the interest rate swap agreement we terminated in August 2011. During the nine months ended September 30, 2011, the interest rate swap agreement generated approximately $8 million of cash interest savings and a $22 million gain on the settlement of the agreement. See Note 5 to the Condensed Consolidated Financial Statements for additional information about this agreement.

Loss from Early Extinguishment of Debt

During the nine months ended September 30, 2010, we recorded a loss from early extinguishment of debt of approximately $55 million, primarily related to the difference between the purchase prices and the par values of the $782 million aggregate principal amount of 7³/₈% senior notes due 2013 that we purchased during the period, as well as the write-off of unamortized note discounts, issuance costs and unrecognized interest rate hedge settlements associated with the notes.

Income Tax Expense

During the nine months ended September 30, 2011, we recorded income tax expense of $73 million compared to a $979 million benefit during the nine months ended September 30, 2010. The increase in income tax expense in the 2011 period is primarily due to the elimination of substantially all of our valuation allowance for deferred tax assets during the three months ended September 30, 2010. We now recognize income tax expense that includes little or no change in the deferred tax valuation allowance, whereas in the 2010 period the tax impact associated with our earnings was substantially offset by the change in the deferred tax valuation allowance. See Note 12 to the Condensed Consolidated Financial Statements for additional detail about these amounts.

ADDITIONAL SUPPLEMENTAL NON-GAAP DISCLOSURES

The financial information provided throughout this report, including our Condensed Consolidated Financial Statements and the notes thereto, has been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). However, we use certain non-GAAP financial measures defined below in communications with investors, analysts, rating agencies, banks and others to assist such parties in understanding the impact of various items on our financial statements, some of which are recurring or involve cash payments. In addition, from time to time we use these measures to define certain performance targets under our compensation programs.

“Adjusted EBITDA” is a non-GAAP measure that we use in our analysis of the performance of our business, which we define as net income (loss) attributable to our common shareholders before: (1) the cumulative effect of changes in accounting principle, net of tax; (2) net income attributable to noncontrolling interests; (3) preferred stock dividends; (4) income (loss) from discontinued operations, net of tax; (5) income tax benefit (expense); (6) investment earnings (loss); (7) gain (loss) from early extinguishment of debt; (8) net gain (loss) on sales of investments; (9) interest expense; (10) litigation and investigation benefit (costs), net of insurance recoveries; (11) hurricane insurance recoveries, net of costs; (12) impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries; and (13) depreciation and amortization. As is the case with all non-GAAP measures, investors should consider the limitations associated with this metric, including the potential lack of comparability of this measure from one company to another, and should recognize that Adjusted EBITDA does not provide a complete measure of our operating performance because it excludes many items that are included in our financial statements. Accordingly, investors are encouraged to use GAAP measures when evaluating our financial performance.

The table below shows the reconciliation of Adjusted EBITDA to net income attributable to our common shareholders (the most comparable GAAP term) for the three and nine months ended September 30, 2011 and 2010:


	Three Months Ended September 30,						Nine Months Ended September 30,
	2011			2010			2011			2010
Net income attributable to Tenet Healthcare Corporation common shareholders	$	6		$	932		$	134		$	1,045
Less: Net income attributable to noncontrolling interests		(3	)		(2	)		(8	)		(7	)
Preferred stock dividends		(6	)		(6	)		(18	)		(18	)
Income (loss) from discontinued operations, net of tax		(2	)		—			4			(5	)

Income from continuing operations		17			940			156			1,075
Income tax benefit (expense)		(4	)		1,002			(73	)		979
Investment earnings		1			3			3			5
Loss from early extinguishment of debt		—			(55	)		—			(55	)
Interest expense		(59	)		(107	)		(275	)		(323	)

Operating income		79			97			501			469
Litigation and investigation costs		(5	)		(2	)		(24	)		(6	)
Impairment of long-lived assets and goodwill, and restructuring charges		(8	)		(3	)		(18	)		(1	)
Depreciation and amortization		(103	)		(101	)		(308	)		(293	)

Adjusted EBITDA	$	195		$	203		$	851		$	769

Net operating revenues	$	2,342		$	2,262		$	7,222		$	6,904

Adjusted EBITDA as % of net operating revenues (Adjusted EBITDA margin)		8.3	%		9.0	%		11.8	%		11.1	%

LIQUIDITY AND CAPITAL RESOURCES

CASH REQUIREMENTS

Certain of our obligations to make future cash payments under contracts as disclosed in our Annual Report increased during the nine months ended September 30, 2011, primarily due to a five-year extension of our existing outsourcing contract for information technology services through 2021, as well as commitments for future professional services under the same contract to be provided to us related to our initiative to achieve full compliance with the ARRA HIT requirements. Our increased cash obligations under this contract approximate $1 billion. In addition, during the nine months ended September 30, 2011, we entered into three contractual agreements for an aggregate commitment of $41 million for future professional services to be provided to us and licensed software fees related to our ARRA HIT initiative. During the nine months ended September 30, 2011, we also entered into non-cancellable capital leases of approximately $15 million, primarily for equipment.

As part of our long-term objective to manage our capital structure, we may from time to time seek to retire, purchase, redeem or refinance some of our outstanding debt or equity securities subject to prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. These actions are part of our strategy to manage our leverage and capital structure over time, which is dependent on our total amount of debt, our cash and our operating results. At September 30, 2011, using the last 12 months of Adjusted EBITDA, our ratio of total long-term debt, net of cash and cash equivalent balances, to Adjusted EBITDA was 3.5x. We anticipate this ratio will fluctuate from quarter to quarter based on earnings performance and other factors. We intend to manage this ratio by following our business plan, managing our cost structure and through other changes in our capital structure, including, if appropriate, the issuance of equity or convertible securities. Our ability to achieve our leverage and capital structure objectives is subject to numerous risks and uncertainties, many of which are described in Item 1A of Part I of our Annual Report.

Our capital expenditures primarily relate to the expansion and renovation of existing facilities (including amounts to comply with applicable laws and regulations), equipment and information systems additions and replacements (including those required to achieve compliance with the HIT requirements under ARRA), introduction of new medical technologies, design and

construction of new buildings, and various other capital improvements. Capital expenditures were $298 million and $280 million in the nine months ended September 30, 2011 and 2010, respectively. We anticipate that our capital expenditures for continuing operations for the year ending December 31, 2011 will total approximately $475 million to $525 million, including $91 million that was accrued as a liability at December 31, 2010. Our anticipated 2011 capital expenditures include approximately $1 million to meet seismic requirements for our California facilities. We currently estimate spending a total of approximately $31 million (of which approximately $27 million was spent prior to January 1, 2011) to comply with the requirements under California’s seismic regulations. Our budgeted capital expenditures for the year ending December 31, 2011 also include approximately $12 million to improve disability access at certain of our facilities as a result of a consent decree in a class action lawsuit. We expect to spend approximately $100 million more on such improvements over the next five years.

Interest payments, net of capitalized interest, were $255 million and $313 million in the nine months ended September 30, 2011 and 2010, respectively.

From time to time, we use interest rate swap agreements to manage our exposure to future changes in interest rates. We were party to an interest rate swap agreement for an aggregate notional amount of $600 million from February 14, 2011 through August 2, 2011. The interest rate swap agreement was designated as a fair value hedge and was being used to manage our exposure to future changes in interest rates. It had the effect of converting our 10% senior secured notes due 2018 from a fixed interest rate paid semi-annually to a variable interest rate paid semi-annually based on the six-month LIBOR plus a floating rate spread of 6.60%. During the term of the interest rate swap agreement, changes in the fair value of the interest rate swap agreement and changes in the fair value of the 10% senior secured notes, which we expected to substantially offset each other, were recorded in interest expense. During the nine months ended September 30, 2011, our interest rate swap agreement generated approximately $8 million of cash interest savings and a $22 million gain on the settlement of the agreement.

Income tax refunds, net of tax payments, were approximately $9 million in the nine months ended September 30, 2011 compared to $34 million during the nine months ended September 30, 2010.

SOURCES AND USES OF CASH

Our liquidity for the nine months ended September 30, 2011 was primarily derived from cash on hand. We had approximately $185 million of cash and cash equivalents on hand at September 30, 2011 to fund our operations and capital expenditures.

Our primary source of operating cash is the collection of accounts receivable. As such, our operating cash flow is negatively impacted by lower levels of cash collections and higher levels of bad debt due to unfavorable shifts in payer mix, growth in admissions of uninsured and underinsured patients, and other factors.

•

Lower interest payments of $58 million (our interest rate swap agreement generated approximately $8 million of cash interest savings and $22 million in proceeds from the termination of the agreement);

•

Reduced cash flows associated with various changes in working capital and changes in long-term liabilities, including the following:

•

a $32 million receivable recorded in the nine months ended September 30, 2011 that is expected to be collected later in 2011 related to state Medicaid ARRA HIT incentives;

•

Income tax refunds of $9 million in the nine months ended September 30, 2011 compared to $34 million in the nine months ended September 30, 2010;

•

Lower payments on reserves for restructuring charges and litigation costs of $49 million; and

•

We continue to seek further initiatives to increase the efficiency of our balance sheet by generating incremental cash. These initiatives include the sale of excess land, buildings or other underutilized or inefficient assets.

Capital expenditures were $298 million and $280 million in the nine months ended September 30, 2011 and 2010, respectively, including approximately $13 million in the nine months ended September 30, 2010 for construction of a replacement hospital for our East Cooper Regional Medical Center in Mount Pleasant, South Carolina.

On May 9, 2011, we announced that our board of directors had authorized the repurchase of up to $400 million of our common stock through a share repurchase program. Under the program, shares may be purchased in the open market or through privately negotiated transactions in a manner consistent with applicable securities laws and regulations, including pursuant to a Rule 10b5-1 plan maintained by the Company. Shares will be repurchased at times and in amounts based on market conditions and other factors. The share repurchase program does not obligate us to acquire any specific number of shares and may be modified, suspended or discontinued at any time. The share repurchase program will expire on May 9, 2012. Pursuant to the share repurchase program, we paid approximately $196 million to repurchase a total of 35,478,972 shares during the period from the commencement of the program through September 30, 2011.

We use fair market value to record our investments that are available-for-sale. As shown in Note 14 to the accompanying Condensed Consolidated Financial Statements, the majority of our investments are valued based on quoted market prices or other observable inputs. We have no investments that we expect will be negatively affected by the current economic downturn that will materially impact our financial condition, results of operations or cash flows.

DEBT INSTRUMENTS, GUARANTEES AND RELATED COVENANTS

We have a senior secured revolving credit facility (“Credit Agreement”) that provides, subject to borrowing availability, for revolving loans in an aggregate principal amount of up to $800 million, with a $300 million subfacility for standby letters of credit. The Credit Agreement is scheduled to expire on October 19, 2015; however, this date could be accelerated to as early as the fourth quarter of 2014 if 80% of our notes due in 2015 are not repaid, defeased or refinanced 60 business days prior to their maturity. We are in compliance with all covenants and conditions in our Credit Agreement. For additional information regarding the Credit Agreement, see Note 5 to the accompanying Condensed Consolidated Financial Statements. Our borrowing availability under the Credit Agreement was $540 million based on our borrowing base calculation as of September 30, 2011. There were no cash borrowings outstanding under the revolving credit facility at September 30, 2011, and we had approximately $169 million of standby letters of credit outstanding.

LIQUIDITY

From time to time, we expect to engage in additional capital markets, bank credit and other financing activities depending on our needs and financing alternatives available at that time. We believe our existing debt agreements provide significant flexibility for future secured or unsecured borrowings.

Our cash on hand fluctuates day-to-day throughout the year based on the timing and levels of routine cash receipts and disbursements, including our book overdrafts, and required cash disbursements, such as interest and income tax payments. These fluctuations result in material intra-quarter net operating and investing uses of cash that could cause us to use our senior secured revolving credit facility as a source of liquidity. During 2011, we could be required to pay the Medicare program approximately $50 million (which we reserved for in prior years) as a result of the SSI matter described under “Disproportionate Share Hospital Payments” in our Annual Report unless CMS changes its policy regarding the inclusion of Medicare Advantage days in the calculation of the SSI ratio prior to its removal of the moratorium on cost report settlements. We would be required to make the payments at the time of the cost report settlements pending the final outcome of our appeals related to this matter. We believe that existing cash and cash equivalents on hand, availability under our revolving credit facility, anticipated future cash provided by operating activities, and our investments in marketable securities of our captive insurance companies classified as noncurrent investments on our balance sheet should be adequate to meet our current cash needs. These sources of liquidity should also be adequate to finance planned capital expenditures, payments on the current portion of our long-term debt and other presently known operating needs.

Long-term liquidity for debt service will be dependent on improved cash provided by operating activities and, given favorable market conditions, future borrowings or refinancings. However, our cash requirements could be materially affected by the use of cash in acquisitions of businesses and repurchases of securities, and also by a deterioration in our results of operations, as well as the various uncertainties discussed in this and other sections of this report, which could require us to pursue any number of financing options, including, but not limited to, additional borrowings, debt refinancings, asset sales or other financing alternatives. The level, if any, of these financing sources cannot be assured.

We do not rely on commercial paper or other short-term financing arrangements nor do we enter into repurchase agreements or other short-term financing arrangements not otherwise reported in our period-end balance sheets.

We continue to aggressively identify and implement further actions to control costs and enhance our operating performance, including cash flow. Among the areas being addressed are volume growth, including the acquisition of outpatient businesses, managed care payer contracting, procurement efficiencies, cost standardization, bad debt expense reduction initiatives, underperforming hospitals, and certain hospital and overhead costs not related to patient care. Although these initiatives may result in improved performance, that performance may remain somewhat below our hospital management peers because of geographic and other differences in hospital portfolios.

OFF-BALANCE SHEET ARRANGEMENTS

Our consolidated operating results from continuing operations for the nine months ended September 30, 2011 and 2010 include $734 million and $718 million, respectively, of net operating revenues and $82 million and $75 million, respectively, of income from operations generated from four general hospitals operated by us under lease arrangements. In accordance with GAAP, the applicable buildings and the future lease obligations under these arrangements are not recorded in our consolidated balance sheet as they are considered operating leases. The current terms of these leases expire between 2014 and 2027, not including lease extensions that we have options to exercise. If these leases expire, we would no longer generate revenue or incur expenses from these hospitals.

We have no other off-balance sheet arrangements that may have a current or future material effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources, except for $263 million of standby letters of credit outstanding and guarantees as of September 30, 2011.

CRITICAL ACCOUNTING ESTIMATES

In preparing our Condensed Consolidated Financial Statements in conformity with GAAP, we must use estimates and assumptions that affect the amounts reported in our Condensed Consolidated Financial Statements and accompanying notes. We regularly evaluate the accounting policies and estimates we use. In general, we base the estimates on historical experience and on assumptions that we believe to be reasonable, given the particular circumstances in which we operate. Actual results may vary from those estimates.

We consider our critical accounting estimates to be those that (1) involve significant judgments and uncertainties, (2) require estimates that are more difficult for management to determine, and (3) may produce materially different outcomes under different conditions or when using different assumptions.

Our critical accounting estimates have not changed from the description provided in our Annual Report.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The table below presents information about certain of our market-sensitive financial instruments as of September 30, 2011. The fair values were determined based on quoted market prices for the same or similar instruments. At September 30, 2011, we had no borrowings with variable interest rates.


	Maturity Date, Years Ending December 31,
	2011			2012			2013			2014			2015			Thereafter			Total			Fair Value
	(Dollars in Millions)
Fixed rate long-term debt	$	72		$	63		$	221		$	61		$	1,189		$	2,670		$	4,276		$	4,319
Average effective interest rates		6.8	%		6.7	%		7.8	%		10.3	%		10.9	%		9.9	%		9.9	%

At September 30, 2011, we had long-term, market-sensitive investments held by our captive insurance subsidiaries. Our market risk associated with our investments in debt securities classified as non-current assets is substantially mitigated by the long-term nature and type of the investments in the portfolio. At September 30, 2011, the net accumulated unrealized losses related to our captive insurance companies’ investment portfolios were less than $1 million.

We have no affiliation with partnerships, trusts or other entities (sometimes referred to as “special-purpose” or “variable-interest” entities) whose purpose is to facilitate off-balance sheet financial transactions or similar arrangements by us. Thus, we have no exposure to the financing, liquidity, market or credit risks associated with such entities.

We do not hold or issue derivative instruments for trading purposes and are not a party to any instruments with leverage or prepayment features.

ITEM 4.

CONTROLS AND PROCEDURES

We carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined by Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended. The evaluation was performed under the supervision and with the participation of management, including our chief executive officer and chief

financial officer. Based upon that evaluation, the chief executive officer and chief financial officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in accumulating and communicating, in a timely manner, the material information related to the Company (including its consolidated subsidiaries) required to be included in our periodic Securities and Exchange Commission filings.

During the third quarter of 2011, there were no changes to our internal control over financial reporting, or in other factors, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

•

Note 11 to the Condensed Consolidated Financial Statements included in this report;

•

Part I, Item 3, Legal Proceedings, of our Annual Report on Form 10-K for the year ended December 31, 2010 (“Annual Report”);

•

Part II, Item 1, Legal Proceedings, of our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2011 (“March 10-Q”); and

•

Part II, Item 1, Legal Proceedings, of our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2011 (“June 10-Q”).

There have been no material changes to the legal proceedings we previously disclosed in our Annual Report, March 10-Q and June 10-Q during the quarter ended September 30, 2011.

ITEM 1A.

RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, Risk Factors, of our Annual Report, which factors could materially affect our business, financial condition or future results of operations.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Repurchase of Common Stock

On May 9, 2011, we announced that our board of directors had authorized the repurchase of up to $400 million of our common stock through a share repurchase program. Under the program, shares may be purchased in the open market or through privately negotiated transactions in a manner consistent with applicable securities laws and regulations, including pursuant to a Rule 10b5-1 plan maintained by the Company. Shares will be repurchased at times and in amounts based on market conditions and other factors. The share repurchase program does not obligate us to acquire any specific number of shares and may be modified, suspended or discontinued at any time. The share repurchase program will expire on May 9, 2012. Information concerning the repurchases of our common stock during the three months ended September 30, 2011 appears under Part I, Item 1, of this report under Note 8 – Equity, and is incorporated herein by reference.

ITEM 6.

EXHIBITS


(4)	Instruments Defining the Rights of Security Holders, Including Indentures

	(a)	Amendment dated as of September 7, 2011 to the Section 382 Rights Agreement, dated as of January 7, 2011, as amended, between the Registrant and the Bank of New York Mellon, as Rights Agent (Incorporated by reference to Exhibit 4.1 to Registrant’s Current Report on Form 8-K, dated and filed September 7, 2011)

(31)	Rule 13a-14(a)/15d-14(a) Certifications

	(a)	Certification of Trevor Fetter, President and Chief Executive Officer

	(b)	Certification of Biggs C. Porter, Chief Financial Officer



(32)		Section 1350 Certifications of Trevor Fetter, President and Chief Executive Officer, and Biggs C. Porter, Chief Financial Officer

(101 INS)		XBRL Instance Document*

(101 SCH)		XBRL Taxonomy Extension Schema Document*

(101 CAL)		XBRL Taxonomy Extension Calculation Linkbase Document*

(101 DEF)		XBRL Taxonomy Extension Definition Linkbase Document*

(101 LAB)		XBRL Taxonomy Extension Label Linkbase Document*

(101 PRE)		XBRL Taxonomy Extension Presentation Linkbase Document*

XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


		TENET HEALTHCARE CORPORATION (Registrant)

Date: October 31, 2011	By:	/S/ DANIEL J. CANCELMI
		Daniel J. Cancelmi Senior Vice President and Controller (Principal Accounting Officer)